JP2847264B2 - Silver halide photographic material and processing method thereof - Google Patents
Silver halide photographic material and processing method thereofInfo
- Publication number
- JP2847264B2 JP2847264B2 JP3103318A JP10331891A JP2847264B2 JP 2847264 B2 JP2847264 B2 JP 2847264B2 JP 3103318 A JP3103318 A JP 3103318A JP 10331891 A JP10331891 A JP 10331891A JP 2847264 B2 JP2847264 B2 JP 2847264B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- silver halide
- mol
- methyl
- emulsion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 Silver halide Chemical class 0.000 title claims description 185
- 229910052709 silver Inorganic materials 0.000 title claims description 57
- 239000004332 silver Substances 0.000 title claims description 57
- 239000000463 material Substances 0.000 title claims description 28
- 238000003672 processing method Methods 0.000 title 1
- 239000000839 emulsion Substances 0.000 claims description 54
- 238000000034 method Methods 0.000 claims description 42
- 239000003446 ligand Substances 0.000 claims description 19
- 238000012545 processing Methods 0.000 claims description 14
- 206010070834 Sensitisation Diseases 0.000 claims description 10
- 230000008313 sensitization Effects 0.000 claims description 10
- 229910052723 transition metal Inorganic materials 0.000 claims description 6
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical group O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 5
- 150000003624 transition metals Chemical class 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 description 52
- 239000000975 dye Substances 0.000 description 37
- 125000004432 carbon atom Chemical group C* 0.000 description 32
- 125000000217 alkyl group Chemical group 0.000 description 29
- 230000001235 sensitizing effect Effects 0.000 description 21
- 239000000460 chlorine Substances 0.000 description 17
- 239000010410 layer Substances 0.000 description 17
- 108010010803 Gelatin Proteins 0.000 description 16
- 239000003795 chemical substances by application Substances 0.000 description 16
- 229920000159 gelatin Polymers 0.000 description 16
- 239000008273 gelatin Substances 0.000 description 16
- 235000019322 gelatine Nutrition 0.000 description 16
- 235000011852 gelatine desserts Nutrition 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- 239000002245 particle Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 12
- 230000035945 sensitivity Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000011161 development Methods 0.000 description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- AVMIKSHFWANHEY-UHFFFAOYSA-L disodium 2-[2-(2-sulfonatophenyl)ethenyl]benzenesulfonate Chemical class [Na+].[Na+].[O-]S(=O)(=O)C1=CC=CC=C1C=CC1=CC=CC=C1S([O-])(=O)=O AVMIKSHFWANHEY-UHFFFAOYSA-L 0.000 description 10
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 10
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 9
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 9
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 9
- 125000003545 alkoxy group Chemical group 0.000 description 9
- 229910052736 halogen Inorganic materials 0.000 description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 9
- 229910052700 potassium Inorganic materials 0.000 description 9
- 239000011591 potassium Substances 0.000 description 9
- 229960003975 potassium Drugs 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 125000003118 aryl group Chemical group 0.000 description 8
- 239000000084 colloidal system Substances 0.000 description 8
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 229910021607 Silver chloride Inorganic materials 0.000 description 7
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 239000010948 rhodium Substances 0.000 description 7
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- ODIRBFFBCSTPTO-UHFFFAOYSA-N 1,3-selenazole Chemical class C1=C[se]C=N1 ODIRBFFBCSTPTO-UHFFFAOYSA-N 0.000 description 6
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical class NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 6
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- KXNQKOAQSGJCQU-UHFFFAOYSA-N benzo[e][1,3]benzothiazole Chemical compound C1=CC=C2C(N=CS3)=C3C=CC2=C1 KXNQKOAQSGJCQU-UHFFFAOYSA-N 0.000 description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 6
- 125000001309 chloro group Chemical group Cl* 0.000 description 6
- YLDMEZNZYLWNNL-UHFFFAOYSA-J diazanium;hexabromoplatinum(2-) Chemical compound [NH4+].[NH4+].[Br-].[Br-].[Br-].[Br-].[Br-].[Br-].[Pt+4] YLDMEZNZYLWNNL-UHFFFAOYSA-J 0.000 description 6
- 150000004820 halides Chemical class 0.000 description 6
- 125000005843 halogen group Chemical group 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- 229910052717 sulfur Chemical group 0.000 description 6
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 5
- 125000002947 alkylene group Chemical group 0.000 description 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 150000002367 halogens Chemical class 0.000 description 5
- 125000000623 heterocyclic group Chemical group 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 229910052741 iridium Inorganic materials 0.000 description 5
- 230000006911 nucleation Effects 0.000 description 5
- 238000010899 nucleation Methods 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 125000000547 substituted alkyl group Chemical group 0.000 description 5
- 239000011593 sulfur Chemical group 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- NSMMFSKPGXCMOE-UHFFFAOYSA-N 2-[2-(2-sulfophenyl)ethenyl]benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1C=CC1=CC=CC=C1S(O)(=O)=O NSMMFSKPGXCMOE-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 150000002460 imidazoles Chemical class 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 4
- AIGNCQCMONAWOL-UHFFFAOYSA-N 1,3-benzoselenazole Chemical compound C1=CC=C2[se]C=NC2=C1 AIGNCQCMONAWOL-UHFFFAOYSA-N 0.000 description 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 3
- GCVFCHUTDVXHBS-UHFFFAOYSA-N 2-[2-(2-sulfonatophenyl)ethenyl]benzenesulfonate triethylazanium Chemical compound C(C)[NH+](CC)CC.C=1(C(=CC=CC1)S(=O)(=O)[O-])C=CC=1C(=CC=CC1)S(=O)(=O)[O-].C(C)[NH+](CC)CC GCVFCHUTDVXHBS-UHFFFAOYSA-N 0.000 description 3
- DSVIHYOAKPVFEH-UHFFFAOYSA-N 4-(hydroxymethyl)-4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(CO)CN1C1=CC=CC=C1 DSVIHYOAKPVFEH-UHFFFAOYSA-N 0.000 description 3
- VWMQXAYLHOSRKA-UHFFFAOYSA-N 5-chloro-1,3-benzoxazole Chemical compound ClC1=CC=C2OC=NC2=C1 VWMQXAYLHOSRKA-UHFFFAOYSA-N 0.000 description 3
- PNJKZDLZKILFNF-UHFFFAOYSA-N 5-methoxy-1,3-benzothiazole Chemical compound COC1=CC=C2SC=NC2=C1 PNJKZDLZKILFNF-UHFFFAOYSA-N 0.000 description 3
- SEBIXVUYSFOUEL-UHFFFAOYSA-N 5-methyl-1,3-benzothiazole Chemical compound CC1=CC=C2SC=NC2=C1 SEBIXVUYSFOUEL-UHFFFAOYSA-N 0.000 description 3
- UBIAVBGIRDRQLD-UHFFFAOYSA-N 5-methyl-1,3-benzoxazole Chemical compound CC1=CC=C2OC=NC2=C1 UBIAVBGIRDRQLD-UHFFFAOYSA-N 0.000 description 3
- NIFNXGHHDAXUGO-UHFFFAOYSA-N 5-phenyl-1,3-benzoxazole Chemical compound C=1C=C2OC=NC2=CC=1C1=CC=CC=C1 NIFNXGHHDAXUGO-UHFFFAOYSA-N 0.000 description 3
- IVKILQAPNDCUNJ-UHFFFAOYSA-N 6-methyl-1,3-benzothiazole Chemical compound CC1=CC=C2N=CSC2=C1 IVKILQAPNDCUNJ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Chemical class 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 125000004104 aryloxy group Chemical group 0.000 description 3
- 229940077388 benzenesulfonate Drugs 0.000 description 3
- WMUIZUWOEIQJEH-UHFFFAOYSA-N benzo[e][1,3]benzoxazole Chemical class C1=CC=C2C(N=CO3)=C3C=CC2=C1 WMUIZUWOEIQJEH-UHFFFAOYSA-N 0.000 description 3
- IIUUNAJWKSTFPF-UHFFFAOYSA-N benzo[g][1,3]benzothiazole Chemical compound C1=CC=CC2=C(SC=N3)C3=CC=C21 IIUUNAJWKSTFPF-UHFFFAOYSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 150000005205 dihydroxybenzenes Chemical class 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 125000001153 fluoro group Chemical group F* 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 239000004848 polyfunctional curative Substances 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000011241 protective layer Substances 0.000 description 3
- 229910001961 silver nitrate Inorganic materials 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 150000003464 sulfur compounds Chemical class 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 229960001367 tartaric acid Drugs 0.000 description 3
- 150000003557 thiazoles Chemical class 0.000 description 3
- 150000003568 thioethers Chemical class 0.000 description 3
- 150000003585 thioureas Chemical class 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- UPPYOQWUJKAFSG-UHFFFAOYSA-N 1,3-benzoxazol-5-ol Chemical compound OC1=CC=C2OC=NC2=C1 UPPYOQWUJKAFSG-UHFFFAOYSA-N 0.000 description 2
- SAHAKBXWZLDNAA-UHFFFAOYSA-N 1,3-benzoxazol-6-ol Chemical compound OC1=CC=C2N=COC2=C1 SAHAKBXWZLDNAA-UHFFFAOYSA-N 0.000 description 2
- GVRURIXNOTXYIW-UHFFFAOYSA-N 1-ethyl-5-(trifluoromethyl)benzimidazole Chemical compound FC(F)(F)C1=CC=C2N(CC)C=NC2=C1 GVRURIXNOTXYIW-UHFFFAOYSA-N 0.000 description 2
- MJKVVDGJSHIKLM-UHFFFAOYSA-N 1-ethyl-5-fluorobenzimidazole Chemical compound FC1=CC=C2N(CC)C=NC2=C1 MJKVVDGJSHIKLM-UHFFFAOYSA-N 0.000 description 2
- OOYWUJOGJNQRCK-UHFFFAOYSA-N 1-ethyl-5-methoxybenzimidazole Chemical compound COC1=CC=C2N(CC)C=NC2=C1 OOYWUJOGJNQRCK-UHFFFAOYSA-N 0.000 description 2
- WVNMLOGVAVGQIT-UHFFFAOYSA-N 1-ethylbenzimidazole Chemical compound C1=CC=C2N(CC)C=NC2=C1 WVNMLOGVAVGQIT-UHFFFAOYSA-N 0.000 description 2
- UHXUPSPGFPYATJ-UHFFFAOYSA-N 1-ethylbenzimidazole-5-carbonitrile Chemical compound N#CC1=CC=C2N(CC)C=NC2=C1 UHXUPSPGFPYATJ-UHFFFAOYSA-N 0.000 description 2
- HLRJOKUMGAFECQ-UHFFFAOYSA-N 1-ethylbenzo[e]benzimidazole Chemical compound C1=CC=CC2=C3N(CC)C=NC3=CC=C21 HLRJOKUMGAFECQ-UHFFFAOYSA-N 0.000 description 2
- FZMXBWXWQILZPU-UHFFFAOYSA-N 1-methyl-5-(trifluoromethyl)benzimidazole Chemical compound FC(F)(F)C1=CC=C2N(C)C=NC2=C1 FZMXBWXWQILZPU-UHFFFAOYSA-N 0.000 description 2
- FGYADSCZTQOAFK-UHFFFAOYSA-N 1-methylbenzimidazole Chemical compound C1=CC=C2N(C)C=NC2=C1 FGYADSCZTQOAFK-UHFFFAOYSA-N 0.000 description 2
- PJHYDBVFHHMVCS-UHFFFAOYSA-N 1-methylbenzimidazole-5-carbonitrile Chemical compound N#CC1=CC=C2N(C)C=NC2=C1 PJHYDBVFHHMVCS-UHFFFAOYSA-N 0.000 description 2
- XNCMQRWVMWLODV-UHFFFAOYSA-N 1-phenylbenzimidazole Chemical compound C1=NC2=CC=CC=C2N1C1=CC=CC=C1 XNCMQRWVMWLODV-UHFFFAOYSA-N 0.000 description 2
- SPXOTSHWBDUUMT-UHFFFAOYSA-N 138-42-1 Chemical compound OS(=O)(=O)C1=CC=C([N+]([O-])=O)C=C1 SPXOTSHWBDUUMT-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- NDUHYERSZLRFNL-UHFFFAOYSA-N 4,6-dimethyl-1,3-benzoxazole Chemical compound CC1=CC(C)=C2N=COC2=C1 NDUHYERSZLRFNL-UHFFFAOYSA-N 0.000 description 2
- IFEPGHPDQJOYGG-UHFFFAOYSA-N 4-chloro-1,3-benzothiazole Chemical compound ClC1=CC=CC2=C1N=CS2 IFEPGHPDQJOYGG-UHFFFAOYSA-N 0.000 description 2
- RJWBTWIBUIGANW-UHFFFAOYSA-M 4-chlorobenzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=C(Cl)C=C1 RJWBTWIBUIGANW-UHFFFAOYSA-M 0.000 description 2
- PIUXNZAIHQAHBY-UHFFFAOYSA-N 4-methyl-1,3-benzothiazole Chemical compound CC1=CC=CC2=C1N=CS2 PIUXNZAIHQAHBY-UHFFFAOYSA-N 0.000 description 2
- ZFIQGRISGKSVAG-UHFFFAOYSA-N 4-methylaminophenol Chemical compound CNC1=CC=C(O)C=C1 ZFIQGRISGKSVAG-UHFFFAOYSA-N 0.000 description 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 description 2
- GYVLFYQMEWXHQF-UHFFFAOYSA-N 5,6-dichloro-1-ethylbenzimidazole Chemical compound ClC1=C(Cl)C=C2N(CC)C=NC2=C1 GYVLFYQMEWXHQF-UHFFFAOYSA-N 0.000 description 2
- KEPMIYWPQKSATD-UHFFFAOYSA-N 5,6-dichloro-1-methylbenzimidazole Chemical compound ClC1=C(Cl)C=C2N(C)C=NC2=C1 KEPMIYWPQKSATD-UHFFFAOYSA-N 0.000 description 2
- MKHRXXZSNOTYND-UHFFFAOYSA-N 5,6-dichloro-1-phenylbenzimidazole Chemical compound C1=2C=C(Cl)C(Cl)=CC=2N=CN1C1=CC=CC=C1 MKHRXXZSNOTYND-UHFFFAOYSA-N 0.000 description 2
- QMUXKZBRYRPIPQ-UHFFFAOYSA-N 5,6-dimethyl-1,3-benzothiazole Chemical compound C1=C(C)C(C)=CC2=C1SC=N2 QMUXKZBRYRPIPQ-UHFFFAOYSA-N 0.000 description 2
- RWNMLYACWNIEIG-UHFFFAOYSA-N 5,6-dimethyl-1,3-benzoxazole Chemical compound C1=C(C)C(C)=CC2=C1OC=N2 RWNMLYACWNIEIG-UHFFFAOYSA-N 0.000 description 2
- ODSGKKPRKQLYDA-UHFFFAOYSA-N 5-(trifluoromethyl)-1,3-benzothiazole Chemical compound FC(F)(F)C1=CC=C2SC=NC2=C1 ODSGKKPRKQLYDA-UHFFFAOYSA-N 0.000 description 2
- KFDDRUWQFQJGNL-UHFFFAOYSA-N 5-bromo-1,3-benzothiazole Chemical compound BrC1=CC=C2SC=NC2=C1 KFDDRUWQFQJGNL-UHFFFAOYSA-N 0.000 description 2
- PGOGTWDYLFKOHI-UHFFFAOYSA-N 5-bromo-1,3-benzoxazole Chemical compound BrC1=CC=C2OC=NC2=C1 PGOGTWDYLFKOHI-UHFFFAOYSA-N 0.000 description 2
- YTSFYTDPSSFCLU-UHFFFAOYSA-N 5-chloro-1,3-benzothiazole Chemical compound ClC1=CC=C2SC=NC2=C1 YTSFYTDPSSFCLU-UHFFFAOYSA-N 0.000 description 2
- XHEABVQBDRMBMU-UHFFFAOYSA-N 5-chloro-1-ethylbenzimidazole Chemical compound ClC1=CC=C2N(CC)C=NC2=C1 XHEABVQBDRMBMU-UHFFFAOYSA-N 0.000 description 2
- DKTVQKUFTJLEGT-UHFFFAOYSA-N 5-chloro-1-methylbenzimidazole Chemical compound ClC1=CC=C2N(C)C=NC2=C1 DKTVQKUFTJLEGT-UHFFFAOYSA-N 0.000 description 2
- HZKQZYHQAFKGAI-UHFFFAOYSA-N 5-chloro-1-phenylbenzimidazole Chemical compound C1=NC2=CC(Cl)=CC=C2N1C1=CC=CC=C1 HZKQZYHQAFKGAI-UHFFFAOYSA-N 0.000 description 2
- GWKNDCJHRNOQAR-UHFFFAOYSA-N 5-ethoxy-1,3-benzothiazole Chemical compound CCOC1=CC=C2SC=NC2=C1 GWKNDCJHRNOQAR-UHFFFAOYSA-N 0.000 description 2
- ANEKYSBZODRVRB-UHFFFAOYSA-N 5-fluoro-1,3-benzothiazole Chemical compound FC1=CC=C2SC=NC2=C1 ANEKYSBZODRVRB-UHFFFAOYSA-N 0.000 description 2
- ZRMPAEOUOPNNPZ-UHFFFAOYSA-N 5-fluoro-1,3-benzoxazole Chemical compound FC1=CC=C2OC=NC2=C1 ZRMPAEOUOPNNPZ-UHFFFAOYSA-N 0.000 description 2
- CJIVGQYHPZZEDW-UHFFFAOYSA-N 5-fluoro-1-methylbenzimidazole Chemical compound FC1=CC=C2N(C)C=NC2=C1 CJIVGQYHPZZEDW-UHFFFAOYSA-N 0.000 description 2
- GLKZKYSZPVHLDK-UHFFFAOYSA-N 5-iodo-1,3-benzothiazole Chemical compound IC1=CC=C2SC=NC2=C1 GLKZKYSZPVHLDK-UHFFFAOYSA-N 0.000 description 2
- IQQKXTVYGHYXFX-UHFFFAOYSA-N 5-methoxy-1,3-benzoxazole Chemical compound COC1=CC=C2OC=NC2=C1 IQQKXTVYGHYXFX-UHFFFAOYSA-N 0.000 description 2
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 2
- AAKPXIJKSNGOCO-UHFFFAOYSA-N 5-phenyl-1,3-benzothiazole Chemical compound C=1C=C2SC=NC2=CC=1C1=CC=CC=C1 AAKPXIJKSNGOCO-UHFFFAOYSA-N 0.000 description 2
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 2
- YJOUISWKEOXIMC-UHFFFAOYSA-N 6-bromo-1,3-benzothiazole Chemical compound BrC1=CC=C2N=CSC2=C1 YJOUISWKEOXIMC-UHFFFAOYSA-N 0.000 description 2
- AIBQGOMAISTKSR-UHFFFAOYSA-N 6-chloro-1,3-benzothiazole Chemical compound ClC1=CC=C2N=CSC2=C1 AIBQGOMAISTKSR-UHFFFAOYSA-N 0.000 description 2
- JJOOKXUUVWIARB-UHFFFAOYSA-N 6-chloro-1,3-benzoxazole Chemical compound ClC1=CC=C2N=COC2=C1 JJOOKXUUVWIARB-UHFFFAOYSA-N 0.000 description 2
- AHOIGFLSEXUWNV-UHFFFAOYSA-N 6-methoxy-1,3-benzothiazole Chemical compound COC1=CC=C2N=CSC2=C1 AHOIGFLSEXUWNV-UHFFFAOYSA-N 0.000 description 2
- FKYKJYSYSGEDCG-UHFFFAOYSA-N 6-methoxy-1,3-benzoxazole Chemical compound COC1=CC=C2N=COC2=C1 FKYKJYSYSGEDCG-UHFFFAOYSA-N 0.000 description 2
- SZWNDAUMBWLYOQ-UHFFFAOYSA-N 6-methylbenzoxazole Chemical compound CC1=CC=C2N=COC2=C1 SZWNDAUMBWLYOQ-UHFFFAOYSA-N 0.000 description 2
- RXEDQOMFMWCKFW-UHFFFAOYSA-N 7-chloro-1,3-benzothiazole Chemical compound ClC1=CC=CC2=C1SC=N2 RXEDQOMFMWCKFW-UHFFFAOYSA-N 0.000 description 2
- WOTSJBCDFDIAHX-UHFFFAOYSA-N ClBr.[Ag].[Ag] Chemical compound ClBr.[Ag].[Ag] WOTSJBCDFDIAHX-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 125000001769 aryl amino group Chemical group 0.000 description 2
- JEHKKBHWRAXMCH-UHFFFAOYSA-N benzenesulfinic acid Chemical compound O[S@@](=O)C1=CC=CC=C1 JEHKKBHWRAXMCH-UHFFFAOYSA-N 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 2
- HJLDPBXWNCCXGM-UHFFFAOYSA-N benzo[f][1,3]benzothiazole Chemical compound C1=CC=C2C=C(SC=N3)C3=CC2=C1 HJLDPBXWNCCXGM-UHFFFAOYSA-N 0.000 description 2
- BVVBQOJNXLFIIG-UHFFFAOYSA-N benzo[g][1,3]benzoxazole Chemical compound C1=CC=CC2=C(OC=N3)C3=CC=C21 BVVBQOJNXLFIIG-UHFFFAOYSA-N 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 150000004696 coordination complex Chemical class 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000006224 matting agent Substances 0.000 description 2
- DZVCFNFOPIZQKX-LTHRDKTGSA-M merocyanine Chemical compound [Na+].O=C1N(CCCC)C(=O)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 DZVCFNFOPIZQKX-LTHRDKTGSA-M 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- KBJMLQFLOWQJNF-UHFFFAOYSA-N nickel(ii) nitrate Chemical compound [Ni+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O KBJMLQFLOWQJNF-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000002916 oxazoles Chemical class 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- GPNDARIEYHPYAY-UHFFFAOYSA-N palladium(ii) nitrate Chemical compound [Pd+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O GPNDARIEYHPYAY-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 2
- 235000019252 potassium sulphite Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 150000003248 quinolines Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229910052703 rhodium Inorganic materials 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- CNHDIAIOKMXOLK-UHFFFAOYSA-N toluquinol Chemical compound CC1=CC(O)=CC=C1O CNHDIAIOKMXOLK-UHFFFAOYSA-N 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
- LUMLZKVIXLWTCI-NSCUHMNNSA-N (e)-2,3-dichloro-4-oxobut-2-enoic acid Chemical compound OC(=O)C(\Cl)=C(/Cl)C=O LUMLZKVIXLWTCI-NSCUHMNNSA-N 0.000 description 1
- MNOZOHCHSDLKAS-UHFFFAOYSA-N (hydroxyamino)carbamic acid Chemical compound ONNC(O)=O MNOZOHCHSDLKAS-UHFFFAOYSA-N 0.000 description 1
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical class C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 1
- FYHIXFCITOCVKH-UHFFFAOYSA-N 1,3-dimethylimidazolidine-2-thione Chemical compound CN1CCN(C)C1=S FYHIXFCITOCVKH-UHFFFAOYSA-N 0.000 description 1
- QTFLUVRZOBQTBW-UHFFFAOYSA-N 1,3-thiazol-3-ium;iodide Chemical compound [I-].C1=CSC=[NH+]1 QTFLUVRZOBQTBW-UHFFFAOYSA-N 0.000 description 1
- IWPGKPWCKGMJMG-UHFFFAOYSA-N 1-(4-aminophenyl)-4,4-dimethylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(C)CN1C1=CC=C(N)C=C1 IWPGKPWCKGMJMG-UHFFFAOYSA-N 0.000 description 1
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 1
- FYBFGAFWCBMEDG-UHFFFAOYSA-N 1-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]prop-2-en-1-one Chemical compound C=CC(=O)N1CN(C(=O)C=C)CN(C(=O)C=C)C1 FYBFGAFWCBMEDG-UHFFFAOYSA-N 0.000 description 1
- FGYADSCZTQOAFK-UHFFFAOYSA-O 1-methyl-1h-benzimidazol-1-ium Chemical compound C1=CC=C2N(C)C=[NH+]C2=C1 FGYADSCZTQOAFK-UHFFFAOYSA-O 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HAZJTCQWIDBCCE-UHFFFAOYSA-N 1h-triazine-6-thione Chemical class SC1=CC=NN=N1 HAZJTCQWIDBCCE-UHFFFAOYSA-N 0.000 description 1
- XIWRQEFBSZWJTH-UHFFFAOYSA-N 2,3-dibromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1Br XIWRQEFBSZWJTH-UHFFFAOYSA-N 0.000 description 1
- DBCKMJVEAUXWJJ-UHFFFAOYSA-N 2,3-dichlorobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Cl)=C1Cl DBCKMJVEAUXWJJ-UHFFFAOYSA-N 0.000 description 1
- AYNPIRVEWMUJDE-UHFFFAOYSA-N 2,5-dichlorohydroquinone Chemical compound OC1=CC(Cl)=C(O)C=C1Cl AYNPIRVEWMUJDE-UHFFFAOYSA-N 0.000 description 1
- GPASWZHHWPVSRG-UHFFFAOYSA-N 2,5-dimethylbenzene-1,4-diol Chemical compound CC1=CC(O)=C(C)C=C1O GPASWZHHWPVSRG-UHFFFAOYSA-N 0.000 description 1
- YKUDHBLDJYZZQS-UHFFFAOYSA-N 2,6-dichloro-1h-1,3,5-triazin-4-one Chemical compound OC1=NC(Cl)=NC(Cl)=N1 YKUDHBLDJYZZQS-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- HIGSPBFIOSHWQG-UHFFFAOYSA-N 2-Isopropyl-1,4-benzenediol Chemical compound CC(C)C1=CC(O)=CC=C1O HIGSPBFIOSHWQG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- PHPYXVIHDRDPDI-UHFFFAOYSA-N 2-bromo-1h-benzimidazole Chemical class C1=CC=C2NC(Br)=NC2=C1 PHPYXVIHDRDPDI-UHFFFAOYSA-N 0.000 description 1
- REFDOIWRJDGBHY-UHFFFAOYSA-N 2-bromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1 REFDOIWRJDGBHY-UHFFFAOYSA-N 0.000 description 1
- AYPSHJCKSDNETA-UHFFFAOYSA-N 2-chloro-1h-benzimidazole Chemical class C1=CC=C2NC(Cl)=NC2=C1 AYPSHJCKSDNETA-UHFFFAOYSA-N 0.000 description 1
- DETXZQGDWUJKMO-UHFFFAOYSA-N 2-hydroxymethanesulfonic acid Chemical compound OCS(O)(=O)=O DETXZQGDWUJKMO-UHFFFAOYSA-N 0.000 description 1
- 229940080296 2-naphthalenesulfonate Drugs 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- LLOAINVMNYBDNR-UHFFFAOYSA-N 2-sulfanylidene-1,3-dihydrobenzimidazole-5-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2NC(=S)NC2=C1 LLOAINVMNYBDNR-UHFFFAOYSA-N 0.000 description 1
- JSIAIROWMJGMQZ-UHFFFAOYSA-N 2h-triazol-4-amine Chemical class NC1=CNN=N1 JSIAIROWMJGMQZ-UHFFFAOYSA-N 0.000 description 1
- CBHTTYDJRXOHHL-UHFFFAOYSA-N 2h-triazolo[4,5-c]pyridazine Chemical class N1=NC=CC2=C1N=NN2 CBHTTYDJRXOHHL-UHFFFAOYSA-N 0.000 description 1
- OWIRCRREDNEXTA-UHFFFAOYSA-N 3-nitro-1h-indazole Chemical class C1=CC=C2C([N+](=O)[O-])=NNC2=C1 OWIRCRREDNEXTA-UHFFFAOYSA-N 0.000 description 1
- OCVLSHAVSIYKLI-UHFFFAOYSA-N 3h-1,3-thiazole-2-thione Chemical class SC1=NC=CS1 OCVLSHAVSIYKLI-UHFFFAOYSA-N 0.000 description 1
- AJKLCDRWGVLVSH-UHFFFAOYSA-N 4,4-bis(hydroxymethyl)-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CO)(CO)CN1C1=CC=CC=C1 AJKLCDRWGVLVSH-UHFFFAOYSA-N 0.000 description 1
- NYYSPVRERVXMLJ-UHFFFAOYSA-N 4,4-difluorocyclohexan-1-one Chemical compound FC1(F)CCC(=O)CC1 NYYSPVRERVXMLJ-UHFFFAOYSA-N 0.000 description 1
- IONPWNMJZIUKJZ-UHFFFAOYSA-N 4,4-dimethyl-1-(4-methylphenyl)pyrazolidin-3-one Chemical compound C1=CC(C)=CC=C1N1NC(=O)C(C)(C)C1 IONPWNMJZIUKJZ-UHFFFAOYSA-N 0.000 description 1
- SJSJAWHHGDPBOC-UHFFFAOYSA-N 4,4-dimethyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(C)CN1C1=CC=CC=C1 SJSJAWHHGDPBOC-UHFFFAOYSA-N 0.000 description 1
- SRYYOKKLTBRLHT-UHFFFAOYSA-N 4-(benzylamino)phenol Chemical compound C1=CC(O)=CC=C1NCC1=CC=CC=C1 SRYYOKKLTBRLHT-UHFFFAOYSA-N 0.000 description 1
- HDGMAACKJSBLMW-UHFFFAOYSA-N 4-amino-2-methylphenol Chemical compound CC1=CC(N)=CC=C1O HDGMAACKJSBLMW-UHFFFAOYSA-N 0.000 description 1
- QMHIMXFNBOYPND-UHFFFAOYSA-N 4-methylthiazole Chemical compound CC1=CSC=N1 QMHIMXFNBOYPND-UHFFFAOYSA-N 0.000 description 1
- UTMDJGPRCLQPBT-UHFFFAOYSA-N 4-nitro-1h-1,2,3-benzotriazole Chemical class [O-][N+](=O)C1=CC=CC2=NNN=C12 UTMDJGPRCLQPBT-UHFFFAOYSA-N 0.000 description 1
- GYVLFYQMEWXHQF-UHFFFAOYSA-O 5,6-dichloro-3-ethyl-1h-benzimidazol-3-ium Chemical compound ClC1=C(Cl)C=C2[N+](CC)=CNC2=C1 GYVLFYQMEWXHQF-UHFFFAOYSA-O 0.000 description 1
- DUMYZVKQCMCQHJ-UHFFFAOYSA-N 5-chloro-1,3-benzoselenazole Chemical compound ClC1=CC=C2[se]C=NC2=C1 DUMYZVKQCMCQHJ-UHFFFAOYSA-N 0.000 description 1
- FMXWRJGEDAMBCO-UHFFFAOYSA-O 5-chloro-1-propyl-1h-benzimidazol-1-ium Chemical compound ClC1=CC=C2[NH+](CCC)C=NC2=C1 FMXWRJGEDAMBCO-UHFFFAOYSA-O 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- AHIHYPVDBXEDMN-UHFFFAOYSA-N 5-methoxy-1,3-benzoselenazole Chemical compound COC1=CC=C2[se]C=NC2=C1 AHIHYPVDBXEDMN-UHFFFAOYSA-N 0.000 description 1
- LDDVDAMRGURWPF-UHFFFAOYSA-N 5-methyl-1,3-benzoselenazole Chemical compound CC1=CC=C2[se]C=NC2=C1 LDDVDAMRGURWPF-UHFFFAOYSA-N 0.000 description 1
- FIARATPVIIDWJT-UHFFFAOYSA-N 5-methyl-1-phenylpyrazolidin-3-one Chemical compound CC1CC(=O)NN1C1=CC=CC=C1 FIARATPVIIDWJT-UHFFFAOYSA-N 0.000 description 1
- WSGURAYTCUVDQL-UHFFFAOYSA-N 5-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2NN=CC2=C1 WSGURAYTCUVDQL-UHFFFAOYSA-N 0.000 description 1
- GIQKIFWTIQDQMM-UHFFFAOYSA-N 5h-1,3-oxazole-2-thione Chemical compound S=C1OCC=N1 GIQKIFWTIQDQMM-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OUBNBOKFXJWJSR-UHFFFAOYSA-N C1(=CC=CC2=CC=CC=C12)OC1=NC(=NC(=C1)OC1=CC=CC2=CC=CC=C12)NC1=C(C(=C(C=C1)C=CC1=CC=C(C=C1)NC1=NC(=CC(=N1)OC1=CC=CC2=CC=CC=C12)OC1=CC=CC2=CC=CC=C12)S(=O)(=O)O)S(=O)(=O)O Chemical compound C1(=CC=CC2=CC=CC=C12)OC1=NC(=NC(=C1)OC1=CC=CC2=CC=CC=C12)NC1=C(C(=C(C=C1)C=CC1=CC=C(C=C1)NC1=NC(=CC(=N1)OC1=CC=CC2=CC=CC=C12)OC1=CC=CC2=CC=CC=C12)S(=O)(=O)O)S(=O)(=O)O OUBNBOKFXJWJSR-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001747 Cellulose diacetate Polymers 0.000 description 1
- 229910020366 ClO 4 Inorganic materials 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PDQAZBWRQCGBEV-UHFFFAOYSA-N Ethylenethiourea Chemical compound S=C1NCCN1 PDQAZBWRQCGBEV-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical class OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229910021638 Iridium(III) chloride Inorganic materials 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- WRUZLCLJULHLEY-UHFFFAOYSA-N N-(p-hydroxyphenyl)glycine Chemical compound OC(=O)CNC1=CC=C(O)C=C1 WRUZLCLJULHLEY-UHFFFAOYSA-N 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229910021605 Palladium(II) bromide Inorganic materials 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004111 Potassium silicate Chemical group 0.000 description 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-O Pyrrolidinium ion Chemical compound C1CC[NH2+]C1 RWRDLPDLKQPQOW-UHFFFAOYSA-O 0.000 description 1
- 229910021604 Rhodium(III) chloride Inorganic materials 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 239000004115 Sodium Silicate Chemical group 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical compound [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 1
- DYPHJEMAXTWPFB-UHFFFAOYSA-N [K].[Fe] Chemical compound [K].[Fe] DYPHJEMAXTWPFB-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000005011 alkyl ether group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000005012 alkyl thioether group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- UMGDCJDMYOKAJW-UHFFFAOYSA-N aminothiocarboxamide Natural products NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 125000001691 aryl alkyl amino group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- NGPGDYLVALNKEG-UHFFFAOYSA-N azanium;azane;2,3,4-trihydroxy-4-oxobutanoate Chemical compound [NH4+].[NH4+].[O-]C(=O)C(O)C(O)C([O-])=O NGPGDYLVALNKEG-UHFFFAOYSA-N 0.000 description 1
- SOJZPUFVOCGQIP-UHFFFAOYSA-M azanium;potassium;2,3-dihydroxybutanedioate Chemical compound [NH4+].[K+].[O-]C(=O)C(O)C(O)C([O-])=O SOJZPUFVOCGQIP-UHFFFAOYSA-M 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000000987 azo dye Substances 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 1
- 229910001864 baryta Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- AMTXUWGBSGZXCJ-UHFFFAOYSA-N benzo[e][1,3]benzoselenazole Chemical compound C1=CC=C2C(N=C[se]3)=C3C=CC2=C1 AMTXUWGBSGZXCJ-UHFFFAOYSA-N 0.000 description 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 125000004112 carboxyamino group Chemical group [H]OC(=O)N([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- AJPXTSMULZANCB-UHFFFAOYSA-N chlorohydroquinone Chemical compound OC1=CC=C(O)C(Cl)=C1 AJPXTSMULZANCB-UHFFFAOYSA-N 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- UFMZWBIQTDUYBN-UHFFFAOYSA-N cobalt dinitrate Chemical compound [Co+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O UFMZWBIQTDUYBN-UHFFFAOYSA-N 0.000 description 1
- 229910001981 cobalt nitrate Inorganic materials 0.000 description 1
- SZAVHWMCBDFDCM-KTTJZPQESA-N cobalt-60(3+);hexacyanide Chemical compound [60Co+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] SZAVHWMCBDFDCM-KTTJZPQESA-N 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 1
- QPJDMGCKMHUXFD-UHFFFAOYSA-N cyanogen chloride Chemical compound ClC#N QPJDMGCKMHUXFD-UHFFFAOYSA-N 0.000 description 1
- OAGAGESCFZXSJR-UHFFFAOYSA-L dichloroosmium Chemical compound Cl[Os]Cl OAGAGESCFZXSJR-UHFFFAOYSA-L 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- BBLSYMNDKUHQAG-UHFFFAOYSA-L dilithium;sulfite Chemical compound [Li+].[Li+].[O-]S([O-])=O BBLSYMNDKUHQAG-UHFFFAOYSA-L 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- LTYMSROWYAPPGB-UHFFFAOYSA-N diphenyl sulfide Chemical group C=1C=CC=CC=1SC1=CC=CC=C1 LTYMSROWYAPPGB-UHFFFAOYSA-N 0.000 description 1
- XOLNQIIEFUNTQC-UHFFFAOYSA-H dipotassium;hexachlororuthenium(2-) Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[K+].[Ru+4] XOLNQIIEFUNTQC-UHFFFAOYSA-H 0.000 description 1
- JITURLXYCMDNGD-UHFFFAOYSA-L disodium;2-(2-sulfonatophenyl)benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=CC=C1C1=CC=CC=C1S([O-])(=O)=O JITURLXYCMDNGD-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- SAIGUZYNPDJAHY-UHFFFAOYSA-N ethane;2-ethenylsulfonylacetamide Chemical compound CC.NC(=O)CS(=O)(=O)C=C SAIGUZYNPDJAHY-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- RJHLTVSLYWWTEF-UHFFFAOYSA-K gold trichloride Chemical compound Cl[Au](Cl)Cl RJHLTVSLYWWTEF-UHFFFAOYSA-K 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 125000004468 heterocyclylthio group Chemical group 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-O hydron;1,3-oxazole Chemical compound C1=COC=[NH+]1 ZCQWOFVYLHDMMC-UHFFFAOYSA-O 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N hydroquinone methyl ether Natural products COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- AKCUHGBLDXXTOM-UHFFFAOYSA-N hydroxy-oxo-phenyl-sulfanylidene-$l^{6}-sulfane Chemical compound SS(=O)(=O)C1=CC=CC=C1 AKCUHGBLDXXTOM-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- HTFVQFACYFEXPR-UHFFFAOYSA-K iridium(3+);tribromide Chemical compound Br[Ir](Br)Br HTFVQFACYFEXPR-UHFFFAOYSA-K 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- UETZVSHORCDDTH-UHFFFAOYSA-N iron(2+);hexacyanide Chemical compound [Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] UETZVSHORCDDTH-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- ZAKLKBFCSHJIRI-UHFFFAOYSA-N mucochloric acid Natural products OC1OC(=O)C(Cl)=C1Cl ZAKLKBFCSHJIRI-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 1
- 125000005184 naphthylamino group Chemical group C1(=CC=CC2=CC=CC=C12)N* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- INIOZDBICVTGEO-UHFFFAOYSA-L palladium(ii) bromide Chemical compound Br[Pd]Br INIOZDBICVTGEO-UHFFFAOYSA-L 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 description 1
- 229940050271 potassium alum Drugs 0.000 description 1
- GNHOJBNSNUXZQA-UHFFFAOYSA-J potassium aluminium sulfate dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GNHOJBNSNUXZQA-UHFFFAOYSA-J 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical group [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 description 1
- 229910052913 potassium silicate Chemical group 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- 229940074439 potassium sodium tartrate Drugs 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- UGZVCHWAXABBHR-UHFFFAOYSA-O pyridin-1-ium-1-carboxamide Chemical class NC(=O)[N+]1=CC=CC=C1 UGZVCHWAXABBHR-UHFFFAOYSA-O 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- HBCQSNAFLVXVAY-UHFFFAOYSA-N pyrimidine-2-thiol Chemical class SC1=NC=CC=N1 HBCQSNAFLVXVAY-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052702 rhenium Inorganic materials 0.000 description 1
- WUAPFZMCVAUBPE-UHFFFAOYSA-N rhenium atom Chemical compound [Re] WUAPFZMCVAUBPE-UHFFFAOYSA-N 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- SONJTKJMTWTJCT-UHFFFAOYSA-K rhodium(iii) chloride Chemical compound [Cl-].[Cl-].[Cl-].[Rh+3] SONJTKJMTWTJCT-UHFFFAOYSA-K 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- BPEVHDGLPIIAGH-UHFFFAOYSA-N ruthenium(3+) Chemical compound [Ru+3] BPEVHDGLPIIAGH-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- CRDYSYOERSZTHZ-UHFFFAOYSA-M selenocyanate Chemical compound [Se-]C#N CRDYSYOERSZTHZ-UHFFFAOYSA-M 0.000 description 1
- 125000001824 selenocyanato group Chemical group *[Se]C#N 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical group [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 235000019794 sodium silicate Nutrition 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- AMZPPWFHMNMIEI-UHFFFAOYSA-M sodium;2-sulfanylidene-1,3-dihydrobenzimidazole-5-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=C2NC(=S)NC2=C1 AMZPPWFHMNMIEI-UHFFFAOYSA-M 0.000 description 1
- MOFJBYOBLBVDJZ-UHFFFAOYSA-N sodium;stilbene Chemical compound C=1C=CC=CC=1C([Na])C([Na])C1=CC=CC=C1 MOFJBYOBLBVDJZ-UHFFFAOYSA-N 0.000 description 1
- BZHOWMPPNDKQSQ-UHFFFAOYSA-M sodium;sulfidosulfonylbenzene Chemical compound [Na+].[O-]S(=O)(=S)C1=CC=CC=C1 BZHOWMPPNDKQSQ-UHFFFAOYSA-M 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 125000004964 sulfoalkyl group Chemical group 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- IYWTUWKWQJIZPO-UHFFFAOYSA-J tetrabromoiridium Chemical compound Br[Ir](Br)(Br)Br IYWTUWKWQJIZPO-UHFFFAOYSA-J 0.000 description 1
- CALMYRPSSNRCFD-UHFFFAOYSA-J tetrachloroiridium Chemical compound Cl[Ir](Cl)(Cl)Cl CALMYRPSSNRCFD-UHFFFAOYSA-J 0.000 description 1
- JJJPTTANZGDADF-UHFFFAOYSA-N thiadiazole-4-thiol Chemical class SC1=CSN=N1 JJJPTTANZGDADF-UHFFFAOYSA-N 0.000 description 1
- 125000005323 thioketone group Chemical group 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000004886 thiomorpholines Chemical class 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- DANYXEHCMQHDNX-UHFFFAOYSA-K trichloroiridium Chemical compound Cl[Ir](Cl)Cl DANYXEHCMQHDNX-UHFFFAOYSA-K 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- NZKWZUOYGAKOQC-UHFFFAOYSA-H tripotassium;hexachloroiridium(3-) Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[K+].[K+].[Ir+3] NZKWZUOYGAKOQC-UHFFFAOYSA-H 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は赤外域が分光増感された
ハロゲン化銀写真感光材料に関するものであり、更に詳
しくは、赤外光の高照度短時間露光において、高感度、
高コントラストかつ迅速処理適性に優れたハロゲン化銀
写真感光材料およびその現像処理方法に関するものであ
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a silver halide photographic material in which the infrared region is spectrally sensitized.
The present invention relates to a silver halide photographic light-sensitive material having high contrast and rapid processing suitability, and a method for developing the same.
【0002】[0002]
【従来の技術】写真感光材料の露光方法の一つに、原図
を走査し、その画像信号に基づいてハロゲン化銀写真感
光材料上に露光を行い、原図の画像に対応するネガ画像
もしくはポジ画像を形成するいわゆるスキャナー方式に
よる画像形成方法が知られている。スキャナー方式によ
る画像形成方法を実用した記録装置は種々あり、これら
のスキャナー方式記録装置の記録用光源には従来グロー
ランプ、キセノンランプ、水銀ランプ、タングステンラ
ンプ、発光ダイオード等が用いられてきた。しかしこれ
らの光源はいずれも出力が小さく寿命が短いという実用
上の欠点を有していた。これらの欠点を補うものとし
て、He−Ne、Ar、He−Cdレーザー等のコヒー
レントなレーザー光源を用いた場合、高出力が得られる
が、装置が大型になる。高価である。変調器が必要とな
る。可視光を用いるために感光材料のセーフライトが制
限され取り扱い性に劣るなどの欠点がある。これに対し
て半導体レーザーは小型で安価、しかも変調が容易であ
り、上記レーザーよりも長寿命でかつ赤外域に発光する
ため、赤外域に感光性を有する感光材料を用いると、明
るいセーフライトが使用できるため取り扱い作業性が良
くなるという利点を有している。しかし半導体レーザー
はレーザービームを特に整形しないでそのまま用いる
と、エネルギー分布がブロードであり、良好な網点画像
や線画像が得られにくい。更に近年は、印刷業界におい
ても作業の効率化、スピードアップは強く望まれてお
り、スキャニングの高速化及び感光材料の処理時間の短
縮化に対する広範囲なニーズが存在している。この様な
ニーズに答えるために感光材料に求められる特性は、高
照度露光において、赤外域に充分な感度を有し、高コン
トラストで、現像進行が速く、迅速処理適性を有するこ
とが望まれる。この様な要求に対して、例えば特開昭6
3−49752では、ハロゲン化銀粒子にイリジウムイ
オンを含有し、赤外域の高照度短時間露光において、高
感、高コントラストであり、かつ、現進性や現像温度依
存性が優れた感光材料を提供する方法が開示されている
がまだ不充分である。2. Description of the Related Art One of the methods for exposing a photographic light-sensitive material is to scan an original drawing and to expose the silver halide photographic light-sensitive material on the basis of an image signal thereof, thereby obtaining a negative image or a positive image corresponding to the image of the original drawing. An image forming method based on a so-called scanner method for forming an image is known. There are various types of recording apparatuses that use a scanner-type image forming method, and a glow lamp, a xenon lamp, a mercury lamp, a tungsten lamp, a light-emitting diode, and the like have been conventionally used as a recording light source of these scanner-type recording apparatuses. However, each of these light sources has a practical disadvantage that the output is small and the life is short. In order to compensate for these drawbacks, when a coherent laser light source such as a He-Ne, Ar, He-Cd laser or the like is used, a high output can be obtained, but the apparatus becomes large. Expensive. A modulator is required. Since visible light is used, there are drawbacks in that safelight of the photosensitive material is limited and handling is inferior. On the other hand, semiconductor lasers are small, inexpensive, easy to modulate, and have a longer life than the above lasers and emit light in the infrared region. There is an advantage that handling operability is improved because it can be used. However, if a semiconductor laser is used without any particular shaping, the energy distribution is broad, and it is difficult to obtain a good halftone image or line image. Furthermore, in recent years, there has been a strong demand in the printing industry for work efficiency and speed-up, and there is a wide range of needs for faster scanning and shorter processing time of photosensitive materials. In order to meet such needs, it is desired that the photosensitive material has sufficient sensitivity in the infrared region, high contrast, rapid development progress, and rapid processing suitability in high illuminance exposure. In response to such a request, for example,
In 3-49752, a photosensitive material which contains iridium ions in silver halide grains, has high sensitivity and high contrast, and is excellent in transitivity and developing temperature dependency in high-intensity short-time exposure in the infrared region. The method of providing has been disclosed but is still inadequate.
【0003】[0003]
【発明が解決しようとする課題】したがって本発明の目
的は、赤外光に対して適切な分光感度を有し、高照度短
時間露光において、高感度、高コントラストでかつ処理
依存性が小さく、迅速処理適性を有するハロゲン化銀写
真感光材料を提供することにある。SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide a device having an appropriate spectral sensitivity to infrared light, a high sensitivity, a high contrast and a small processing dependency in short-time exposure with high illuminance, An object of the present invention is to provide a silver halide photographic light-sensitive material having suitability for rapid processing.
【0004】[0004]
【課題を解決するための手段】本発明のこれら目的は、
支持体上に少なくとも1層のハロゲン化銀乳剤層を有す
るハロゲン化銀写真感光材料において、該ハロゲン化銀
乳剤が、ニトロシル又はチオニトロシル配位子を有する
周期律表の第Va〜VIIa族またはVIII族の元素から選択
される遷移金属を含有するハロゲン化銀粒子からなり、
かつ増感極大が750nmより長波長に分光増感されて
いることを特徴とするハロゲン化銀写真感光材料により
達成された。SUMMARY OF THE INVENTION These objects of the invention are:
In a silver halide photographic light-sensitive material having at least one silver halide emulsion layer on a support, the silver halide emulsion preferably has a nitrosyl or thionitrosyl ligand, a group Va to VIIa or VIIIa of the periodic table. Consisting of silver halide grains containing a transition metal selected from the group elements,
The silver halide photographic light-sensitive material is characterized in that the sensitization maximum is spectrally sensitized to a wavelength longer than 750 nm.
【0005】以下に本発明の具体的構成について詳細に
説明する。本発明の目的を達成する遷移金属配位子錯体
の好ましいものとしては、下記の一般式で表わされる六
配位錯体である。 〔M(MY)L5 〕m (式中、Mは元素の周期律表の第Va〜VIIaまたはVIII
族の元素から選ばれる遷移金属である。元素の周期及び
族はIUPACの命名に従っている。Lは架橋配位子で
あり1つ(NY)で置換していても良い。Yは酸素又は
硫黄である。m=1、−1、−2、−3である。)ニト
ロシル及びチオニトロシル架橋配位子以外のLの好まし
い具体例としては、ハロゲン化物配位子(フッ化物、塩
化物、臭化物及びヨウ化物)、シアン化物配位子、シア
ネート配位子、チオシアネート配位子、セレノシアネー
ト配位子、テルロシアネート配位子、アジド配位子及び
アコ配位子が挙げられる。アコ配位子が存在する場合に
は、配位子の1つ又は2つを占めることが好ましい。M
の特に好ましい具体例は、ロジウム、ルテニウム、レニ
ウム、オスミウム、イリジウムである。以下に遷移金属
配位錯体の具体例を示す。 1 〔Ru(NO)Cl5 〕-2 2 〔Ru(NO)2 Cl4 〕-1 3 〔Ru(NO)(H2 O)Cl4 〕-1 4 〔Rh(NO)Cl5 〕-2 5 〔Re(NO)Cl5 〕-2 6 〔Re(NO)CN5 〕-2 7 〔Re(NO)ClCN4 〕-2 8 〔Rh(NO)2 Cl4 〕-1 9 〔Rh(NO)(H2 O)Cl4 〕-1 10 〔Ru(NO)CN5 〕-2 11 〔Ru(NO)Br5 〕-2 12 〔Rh(NS)Cl5 〕-2 13 〔Os(NO)Cl5 〕-2 14 〔Cr(NO)Cl5 〕-3 15 〔Re(NO)Cl5 〕-1 16 〔Os(NS)Cl4 (TeCN)〕-2 17 〔Ru(NS)I5 〕-2 18 〔Re(NS)Cl4 (SeCN)〕-2 19 〔Os(NS)Cl(SCN)4 〕-2 20 〔Ir(NO)Cl5 〕-2 Hereinafter, a specific configuration of the present invention will be described in detail. A preferred transition metal ligand complex for achieving the object of the present invention is a hexacoordinate complex represented by the following general formula. [M (MY) L 5 ] m , wherein M is Va to VIIa or VIII of the periodic table of the elements.
It is a transition metal selected from group elements. The period and group of the elements follow the IUPAC nomenclature. L is a bridging ligand and may be substituted with one (NY). Y is oxygen or sulfur. m = 1, -1, -2, -3. Preferred examples of L other than nitrosyl and thionitrosyl bridging ligands include halide ligands (fluoride, chloride, bromide and iodide), cyanide ligand, cyanate ligand, thiocyanate ligand. Ligands, selenocyanate ligands, tellurocyanate ligands, azide ligands and aquo ligands. If an aquo ligand is present, it preferably occupies one or two of the ligands. M
Particularly preferred embodiments of are rhodium, ruthenium, rhenium, osmium and iridium. Specific examples of the transition metal coordination complex are shown below. 1 [Ru (NO) Cl 5 ] -22 [Ru (NO) 2 Cl 4 ] -13 [Ru (NO) (H 2 O) Cl 4 ] -14 [Rh (NO) Cl 5 ] -2 5 [Re (NO) Cl 5] -2 6 [Re (NO) CN 5] -2 7 [Re (NO) ClCN 4] -2 8 [Rh (NO) 2 Cl 4] -1 9 [Rh (NO ) (H 2 O) Cl 4] -1 10 [Ru (NO) CN 5] -2 11 [Ru (NO) Br 5] -2 12 [Rh (NS) Cl 5] -2 13 [Os (NO) Cl 5] -2 14 [Cr (NO) Cl 5] -3 15 [Re (NO) Cl 5] -1 16 [Os (NS) Cl 4 (TeCN ) ] -2 17 [Ru (NS) I 5] -2 18 [Re (NS) Cl 4 (SeCN)] -2 19 [Os (NS) Cl (SCN) 4 ] -2 20 [Ir (NO) Cl 5 ] -2
【0006】上記金属錯体をハロゲン化銀に含有せしめ
るには、粒子調製時に添加することができる。本発明の
ハロゲン化銀粒子中に該遷移金属の含有率はハロゲン化
銀1モル当り少なくとも10-8〜1×10-6モルである
が好ましくは10-7〜5×10-7モルである。本発明の
ハロゲン化銀粒子は上記ニトロシル、チオニトロシル配
位子を有する金属錯体以外に異なった配位子を有する金
属を併用することができる。本発明において好ましく用
いられるこれらの金属を含む化合物としては、硫酸鉄(I
I)FeSO4 −5H2 O;塩化鉄(III) FeCl3 ;ヘ
キサシアノ鉄(II)鉄カリウムK4 Fe(CN)6 ・3H
2 O;ヘキサシアノ鉄(III) 鉄カリウムK3 Fe(C
N)6 ;塩化コバルト(II)CoCl2 ;硝酸コバルト(I
I)Co(NO3 )2 ・6H2 O;ヘキサシアノコバルト
(III) 酸カリウムK3 Co(CN)6 ;塩化ニッケル(I
I)NiCl2 ;6H2 O硝酸ニッケル(II)Ni(N
O3 )2 ・6H2 O;塩化ルテニウム(III)RuC
l3 ;ヘキサクロロルテニウム(IV)酸カリウム・K2 R
uCl6 ;塩化ロジウム(III) RhCl3 ・4H2 O;
ヘキサクロロロジウム(III) 酸アンモニウム(NH)3
RhCl6 ;塩化パラジウム(II)PdCl2 ;硝酸パラ
ジウム(II)Pd(NO3 )2 ;臭化パラジウム(II)Pd
Br2 ;ヘキサクロロパラジウム(IV)酸カリウムK2 P
dCl6 ;テトラチオパラジウム(II)酸カリウム・K2
Pd(CNS)4 ;塩化オスミウム(II)OsCl2 ;塩
化イリジウム(III) IrCl3 ;塩化イリジウム(IV)I
rCl4 ;臭化イリジウム(III) IrBr3 ・4H
2 O;臭化イリジウム(IV)IrBr4 ;ヘキサクロロイ
リジウム(III) 酸カリウムK3 IrCl6 ;ヘキサクロ
ロイリジウム(IV)酸カリウムK2 IrCl6 ;ヘキサク
ロロ白金(IV)酸アンモニウム(NH4)2 PtCl6 ;
ヘキサクロロ白金(IV)酸カリウムK2 PtCl6 ;ヘキ
サブロモ白金(IV)酸アンモニウム(NH4 )2 PtBr
6 ;などがある。これらの金属化合物は、ハロゲン化銀
1モル当たり10-9モルから10-3モルに相当する量で
単独で用いられまたは2種以上の化合物が併用される。In order to incorporate the above metal complex into silver halide, it can be added during grain preparation. The content of the transition metal in the silver halide grains of the present invention is at least 10 -8 to 1 × 10 -6 mol, preferably 10 -7 to 5 × 10 -7 mol, per mol of silver halide. . In the silver halide grains of the present invention, a metal having a different ligand can be used in addition to the metal complex having a nitrosyl or thionitrosyl ligand. Compounds containing these metals preferably used in the present invention include iron sulfate (I
I) FeSO 4 -5H 2 O; iron chloride (III) FeCl 3; hexacyanoferrate (II) iron potassium K4 Fe (CN) 6 · 3H
2 O; Hexacyanoiron (III) iron potassium K 3 Fe (C
N) 6 ; cobalt (II) chloride CoCl 2 ; cobalt nitrate (I
I) Co (NO 3) 2 · 6H 2 O; hexacyanocobaltate
(III) potassium salt K 3 Co (CN) 6 ; nickel chloride (I
I) NiCl 2 ; 6H 2 O nickel (II) nitrate Ni (N
O 3) 2 · 6H 2 O ; ruthenium (III) Ruc
l 3 ; potassium hexachlororuthenate (IV) ・ K 2 R
uCl 6 ; rhodium (III) chloride RhCl 3 .4H 2 O;
Ammonium hexachlororhodate (III) (NH) 3
RhCl 6 ; Palladium (II) chloride PdCl 2 ; Palladium (II) nitrate Pd (NO 3 ) 2 ; Palladium (II) bromide Pd
Br 2 ; potassium hexachloropalladate (IV) K 2 P
dCl 6 ; potassium tetrathiopalladium (II) ・ K 2
Pd (CNS) 4 ; Osmium (II) chloride OsCl 2 ; Iridium (III) chloride IrCl 3 ; Iridium (IV) chloride I
RCL 4; bromide iridium (III) IrBr 3 · 4H
2 O; iridium (IV) bromide IrBr 4 ; potassium hexachloroiridate (III) K 3 IrCl 6 ; potassium hexachloroiridate (IV) K 2 IrCl 6 ; ammonium hexachloroplatinate (IV) ammonium (NH 4 ) 2 PtCl 6 ;
Potassium hexachloroplatinate (IV) K 2 PtCl 6 ; ammonium hexabromoplatinate (IV) ammonium (NH 4 ) 2 PtBr
6 ; These metal compounds are used alone or in combination of two or more in an amount corresponding to 10 -9 mol to 10 -3 mol per mol of silver halide.
【0007】本発明に用いられるハロゲン化銀乳剤のハ
ロゲン組成には特に制限はないが、迅速処理適性から
は、塩化銀含有率が50モル%以上である沃塩臭化銀ま
たは塩臭化銀が好ましい。本発明におけるハロゲン化銀
乳剤の平均粒子サイズは0.7μm以下が好ましく、よ
り好ましくは、0.2μm〜0.5μmである。粒子サ
イズ分布は、単分散が好ましい。The halogen composition of the silver halide emulsion used in the present invention is not particularly limited, but from the viewpoint of rapid processing suitability, silver iodochlorobromide or silver chlorobromide having a silver chloride content of 50 mol% or more is preferred. Is preferred. The average grain size of the silver halide emulsion in the present invention is preferably 0.7 μm or less, more preferably 0.2 μm to 0.5 μm. The particle size distribution is preferably monodisperse.
【0008】ここでいう単分散粒子とは、変動係数が、
20%以下、特に好ましくは15%以下である粒子サイ
ズ分布を有するハロゲン化銀乳剤を意味する。変動係数
(%)とはハロゲン化銀粒子の粒径の標準偏差を粒径の
平均値で除して100倍した値で示される。本発明にお
けるハロゲン化銀粒子は実質的に(100)面から成る
立方体状の粒子であることが好ましい。ここで「実質的
に(100)面から成る」とは具体的にはハロゲン化銀
乳剤に含まれる粒子のうち、好ましくは50%以上、よ
り好ましくは80%以上、特に好ましくは95%以上の
数の粒子が立方体およびまたは粒子の表面積の60%以
上を(100)面が占めているような粒子から成ること
を意味している。本発明に用いられる写真乳剤は、P.Gl
afkides 著Chimie et Physique Photographique(Paul M
ontel 社刊、1967年)、G.F.Duffin著Photographic
Emulsion Chemistry(The Focal Press 刊、1966
年)、V.L.Zelikman et al著 Making and Coating Phot
ographic Emulsion(The Focal Press 刊、1964年)
などに記載された方法を用いて調製することができる。
即ち、酸性法、中性法、アンモニア法等のいずれでもよ
く、又可溶性銀塩と可溶性ハロゲン塩を反応させる形成
としては、片側混合法、同時混合法、それらの組合せな
どのいずれを用いてもよい。粒子を銀イオン過剰の下に
おいて形成させる方法(いわゆる逆混合法)を用いるこ
ともできる。同時混合法の一つの形式としてハロゲン化
銀の生成される液相中のpAgを一定に保つ方法、即
ち、いわゆるコントロールド、ダブルジェット法を用い
ることもできる。この方法によると、結晶形が規則的で
粒子サイズが均一に近いハロゲン化銀乳剤が得られる。
また、粒子サイズを均一にするためには、英国特許1,
535,016号、特公昭48−36890、同52−
16364号に記載されているように、硝酸銀やハロゲ
ン化アルカリの添加速度を粒子成長速度に応じて変化さ
せる方法や、英国特許4,242,445号、特開昭5
5−158124号に記載されているように水溶液の濃
度を変化させる方法を用いて、臨界飽和度を超えない範
囲において早く成長させることが好ましい。ハロゲン化
銀粒子は、内部と表層とが異なるハロゲン組成を有す
る、いわゆるコア/シェル型構造を有しても良い。The monodisperse particles referred to here have a coefficient of variation of
It means a silver halide emulsion having a grain size distribution of not more than 20%, particularly preferably not more than 15%. The coefficient of variation (%) is a value obtained by dividing the standard deviation of the grain size of silver halide grains by the average value of the grain sizes and multiplying the result by 100. The silver halide grains in the present invention are preferably cubic grains having substantially (100) faces. Here, “consisting substantially of (100) plane” specifically means that preferably 50% or more, more preferably 80% or more, and particularly preferably 95% or more of the grains contained in the silver halide emulsion. It is meant that the number of particles consists of cubes and / or particles such that the (100) plane occupies more than 60% of the surface area of the particles. The photographic emulsion used in the present invention is P.Gl
afkides, Chimie et Physique Photographique (Paul M
ontel, 1967), Photographic by GFDuffin
Emulsion Chemistry (The Focal Press, 1966
Year), Making and Coating Phot by VLZelikman et al
ographic Emulsion (The Focal Press, 1964)
It can be prepared using the method described in, for example.
That is, any of an acidic method, a neutral method, an ammonia method and the like may be used, and a method of reacting a soluble silver salt with a soluble halide may be any one of a one-sided mixing method, a double-sided mixing method, and a combination thereof. Good. A method of forming grains in the presence of excess silver ions (a so-called reverse mixing method) can also be used. As one type of the double jet method, a method in which pAg in a liquid phase in which silver halide is formed is kept constant, that is, a so-called controlled double jet method can be used. According to this method, a silver halide emulsion having a regular crystal form and a nearly uniform grain size can be obtained.
In order to make the particle size uniform, British Patent 1,
No. 535,016, JP-B-48-36890, 52-
No. 16,364, a method in which the addition rate of silver nitrate or an alkali halide is changed in accordance with the grain growth rate, a method disclosed in British Patent No. 4,242,445,
It is preferable to use a method of changing the concentration of the aqueous solution as described in JP-A-5-158124 to grow the solution quickly within a range not exceeding the critical saturation. The silver halide grains may have a so-called core / shell structure in which the inside and the surface have different halogen compositions.
【0009】本発明のハロゲン化銀乳剤の粒子形成は、
四置換チオ尿素、有機チオエーテル化合物の如きハロゲ
ン化銀溶剤の存在下で行うことが好ましい。本発明で用
いられる好ましい四置換チオ尿素ハロゲン化銀溶剤は、
特開昭53−82408、同55−77737などに記
載された次の一般式で表わされる化合物である。The grain formation of the silver halide emulsion of the present invention comprises
It is preferable to carry out the reaction in the presence of a silver halide solvent such as a tetrasubstituted thiourea or an organic thioether compound. Preferred tetrasubstituted thiourea silver halide solvent used in the present invention is
It is a compound represented by the following general formula described in JP-A-53-82408 and JP-A-55-77737.
【0010】[0010]
【化1】 Embedded image
【0011】式中、R1 、R2 、R3 およびR4 は、置
換または未置換のアルキル基、アルケニル基(アリル基
など)、あるいは、置換または未置換のアリールを表わ
し、これらは互いに同じでも異なってもよく、R1 〜R
4 の炭素数の合計は30以下が好ましい。また、R1 と
R2 、R2 とR3、あるいはR3 とR4 で結合して5な
いし6員の複素環イミダゾリジンチオン、ピペリジン、
モルホリンなどを作ることもできる。上記アルキル基は
直鎖又は分岐のものの両方が用いられる。アルキル基の
置換基としては、例えばヒドロキシ基(−OH)、カル
ボキシ基、スルホン酸基、アミノ基、アルキル残基が1
〜5個の炭素原子を有するアルコキシ基(o−アルキ
ル)、フェニル基または5ないし6員の複素環(フラン
など)である。アリール基の置換基としては、ヒドロキ
シ基、カルボキシ基またはスルホン酸基である。ここ
で、特に好ましくは、R1 〜R4 のうち、アルキル基が
3つ以上で、各アルキル基の炭素数は1〜5、アリール
基はフェニル基、さらにR1 〜R4 の炭素数の合計は2
0以下である。本発明に用いることのできる化合物の例
として次のものを挙げることができる。In the formula, R 1 , R 2 , R 3 and R 4 represent a substituted or unsubstituted alkyl group, an alkenyl group (such as an allyl group) or a substituted or unsubstituted aryl, and these are the same as each other. Or different, R 1 to R
The total number of carbon atoms in 4 is preferably 30 or less. And a 5- or 6-membered heterocyclic imidazolidinethione, piperidine, which is bonded by R 1 and R 2 , R 2 and R 3 , or R 3 and R 4 ;
Morpholine can also be made. Both linear and branched alkyl groups are used. Examples of the substituent of the alkyl group include a hydroxy group (—OH), a carboxy group, a sulfonic acid group, an amino group, and an alkyl residue.
It is an alkoxy group (o-alkyl) having up to 5 carbon atoms, a phenyl group or a 5- or 6-membered heterocyclic ring (such as furan). The substituent of the aryl group is a hydroxy group, a carboxy group or a sulfonic group. Here, particularly preferably of R 1 to R 4, the alkyl group has 3 or more carbon atoms in each alkyl group has from 1 to 5, aryl is a phenyl group, further the R 1 to R 4 carbon atoms Total is 2
0 or less. Examples of the compounds that can be used in the present invention include the following.
【0012】[0012]
【化2】 Embedded image
【0013】[0013]
【化3】 Embedded image
【0014】[0014]
【化4】 Embedded image
【0015】本発明に好ましく用いられる有機チオエー
テルハロゲン化銀溶剤は例えば特公昭47−11386
号(米国特許3,574,628号)等に記載された酸
素原子と硫黄原子がエチレンによりへだてられている基
(例えば−O−CH2 CH2 −S−)を少なくとも1つ
含む化合物、特開昭54−155828号(米国特許
4,276,374号)に記載された両端にアルキル基
(このアルキル基は各々ヒドロキシ、アミノ、カルボキ
シ、アミド又はスルホンの中から選ばれる少なくとも2
個の置換基を有する)を持つ鎖状のチオエーテル化合物
である。具体的には次のような例を挙げることができ
る。The organic thioether silver halide solvent preferably used in the present invention is, for example, JP-B-47-11386.
No. (U.S. Patent No. 3,574,628) comprising at least one compound group wherein oxygen atom and a sulfur atom are separated by an ethylene (e.g. -O-CH 2 CH 2 -S-) in the like, especially An alkyl group at both ends described in Japanese Unexamined Patent Publication No. 54-155828 (U.S. Pat. No. 4,276,374) wherein each alkyl group is at least two groups selected from hydroxy, amino, carboxy, amide or sulfone
Thioether compound having two substituents). Specifically, the following examples can be given.
【0016】[0016]
【化5】 Embedded image
【0017】ハロゲン化銀溶剤の添加量は、用いる化合
物の種類および目的とする粒子サイズ、ハロゲン組成な
どにより異なるが、ハロゲン化銀1モルあたり10-5〜
10-2モルが好ましい。ハロゲン化銀溶剤の使用により
目的以上の粒子サイズになる場合は粒子形成時の温度、
銀塩溶液、ハロゲン塩溶液の添加時間などを変えること
により所望の粒子サイズにすることができる。The amount of the silver halide solvent to be added varies depending on the kind of the compound used, the intended grain size, the halogen composition, and the like, but is 10 -5 to 1 mol per mol of the silver halide.
10 -2 mol is preferred. If the grain size exceeds the target by using a silver halide solvent, the temperature during grain formation,
A desired particle size can be obtained by changing the addition time of the silver salt solution or the halogen salt solution.
【0018】本発明のハロゲン化銀乳剤は金増感および
硫黄増感されることが好ましい。本発明に用いられる金
増感剤としては種々の金塩であり例えばカリウムクロロ
オーライト、カリウムオーリックチオシアネート、カリ
ウムクロロオーレート、オーリックトリクロライド等が
ある。具体例は米国特許2399083号、同2642
361号明細書に記載されている。本発明に用いられる
硫黄増感剤としては、ゼラチン中に含まれる硫黄化合物
のほか、種々の硫黄化合物、たとえばチオ硫酸塩、チオ
尿素類、チアゾール類、ローダニン類等を用いることが
できる。具体例は米国特許1,574,944号、同
2,278,947号、同2,410,689号、同
2,728,668号、同3,501,313号、同
3,656,955号に記載されたものである。好まし
い硫黄化合物は、チオ硫酸塩、チオ尿素化合物である。
好ましい硫黄増感剤および金増感剤の添加量は銀モルあ
たり10-2〜10-7モルでありより好ましくは1×10
-3〜1×10-5モルである。硫黄増感剤と金増感剤の比
率はモル比で1:3〜3:1であり好ましくは1:2〜
2:1である。本発明において、還元増感法を用いるこ
とができる。還元増感剤としては第一すず塩、アミン
類、ホルムアミジンスルフィン酸、シラン化合物などを
用いることができる。The silver halide emulsion of the present invention is preferably subjected to gold sensitization and sulfur sensitization. The gold sensitizer used in the present invention is various gold salts such as potassium chloroaulite, potassium auric thiocyanate, potassium chloroaurate, and auric trichloride. Specific examples are described in U.S. Pat.
No. 361. As the sulfur sensitizer used in the present invention, various sulfur compounds such as thiosulfates, thioureas, thiazoles, rhodanines and the like can be used in addition to the sulfur compounds contained in gelatin. Specific examples are described in U.S. Pat. Nos. 1,574,944, 2,278,947, 2,410,689, 2,728,668, 3,501,313, and 3,656,955. It is described in the issue. Preferred sulfur compounds are thiosulfates and thiourea compounds.
The added amount of the sulfur sensitizer and the gold sensitizer is preferably 10 −2 to 10 −7 mol per mol of silver, more preferably 1 × 10 7 mol.
-3 to 1 × 10 -5 mol. The molar ratio of the sulfur sensitizer to the gold sensitizer is 1: 3 to 3: 1, preferably 1: 2 to 2: 1.
2: 1. In the present invention, a reduction sensitization method can be used. Stannous salts, amines, formamidinesulfinic acid, silane compounds and the like can be used as the reduction sensitizer.
【0019】本発明のハロゲン化銀乳剤は、特開平2−
264935号に示される方法により、チオスルホン酸
化合物を添加しても良い。The silver halide emulsion of the present invention is disclosed in
A thiosulfonic acid compound may be added by the method described in JP-A-264935.
【0020】本発明のハロゲン化銀乳剤は、750nm
以上の波長域に極大をもつように赤外増感される。赤外
増感のための増感色素としては何を使用しても良いが、
増感の性能及び安定性の点から、下記に示す一般式で表
わされる色素を用いるのが特に好ましい。以下にそれら
の一般式および具体的化合物例を示す。The silver halide emulsion of the present invention has a thickness of 750 nm.
Infrared sensitization is performed to have a maximum in the above wavelength range. Any sensitizing dye for infrared sensitization may be used,
From the viewpoint of sensitizing performance and stability, it is particularly preferable to use a dye represented by the following general formula. The general formulas and specific compound examples are shown below.
【0021】[0021]
【化6】 Embedded image
【0022】式中、R1 及びR2 は各々同一であっても
異っていてもよく、それぞれアルキル基(置換アルキル
基をふくむ)を表わす。好ましくは炭素原子数1〜8。
例えばメチル、エチル、プロピル、ブチル、ペンチル、
ヘプチル、オクチル。置換基としては例えばカルボキシ
ル基、スルホ基、シアノ基、ハロゲン原子(例えばフッ
素原子、塩素原子、臭素原子)、ヒドロキシル基、アル
コキシカルボニル基(好ましくは、炭素原子数8以下、
例えばメトキシカルボニル、エトキシカルボニル、ベン
ジルオキシカルボニルなど)、アルコキシ基(好ましく
は炭素原子数7以下、例えばメトキシ、エトキシ、プロ
ポキシ、ブトキシ、ベンジルオキシ)、アリールオキシ
基(例えばフェノキシ、p−トリルオキシ)、アシルオ
キシ基(好ましくは炭素原子数3以下、例えばアセチル
オキシ、プロピオニルオキシ)、アシル基(好ましくは
炭素原子数8以下、例えばアセチル、プロピオニル、ベ
ンゾイル、メシル)、カルバモイル基(例えばカルバモ
イル、N,N−ジメチルカルバモイル、モルホリノカル
バモイル、ピペリジノカルバモイル)、スルファモイル
基(例えばスルファモイル、N,N−ジメチルスルファ
モイル、モルホリノスルホニル)、アリール基(例えば
フェニル、p−ヒドロキシフェニル、p−カルボキシフ
ェニル、p−スルホフェニル、α−ナフチル)などで置
換されたアルキル基(好ましくはアルキル部分の炭素原
子数6以下)が挙げられる。但し、この置換基は2つ以
上組合せてアルキル基に置換されてよい。In the formula, R 1 and R 2 may be the same or different and each represents an alkyl group (including a substituted alkyl group). Preferably it has 1 to 8 carbon atoms.
For example, methyl, ethyl, propyl, butyl, pentyl,
Heptyl, octyl. Examples of the substituent include a carboxyl group, a sulfo group, a cyano group, a halogen atom (for example, a fluorine atom, a chlorine atom, and a bromine atom), a hydroxyl group, an alkoxycarbonyl group (preferably having 8 or less carbon atoms,
For example, methoxycarbonyl, ethoxycarbonyl, benzyloxycarbonyl, etc.), an alkoxy group (preferably having 7 or less carbon atoms, for example, methoxy, ethoxy, propoxy, butoxy, benzyloxy), an aryloxy group (eg, phenoxy, p-tolyloxy), acyloxy Groups (preferably having 3 or less carbon atoms, such as acetyloxy, propionyloxy), acyl groups (preferably having 8 or less carbon atoms, such as acetyl, propionyl, benzoyl, mesyl), carbamoyl groups (such as carbamoyl, N, N-dimethyl) Carbamoyl, morpholinocarbamoyl, piperidinocarbamoyl), sulfamoyl group (eg, sulfamoyl, N, N-dimethylsulfamoyl, morpholinosulfonyl), aryl group (eg, phenyl, p-hi) Rokishifeniru, p- carboxyphenyl, p- sulfophenyl, alpha-naphthyl) substituted alkyl groups (preferably having 6 or less carbon atoms in the alkyl moiety) are exemplified by such. However, two or more of these substituents may be substituted with an alkyl group.
【0023】R3 は水素原子、低級アルキル基(好まし
くは炭素原子数1〜4、例えばメチル、エチル、プロピ
ル、ブチル)、低級アルコキシ基(好ましくは炭素原子
数1〜4、例えばメトキシ、エトキシ、プロポキシ、ブ
トキシ)、フェニル基、ベンジル基又はフェネチル基を
表わす。特に低級アルキル基、ベンジル基が有利に用い
られる。Vは水素原子、低級アルキル基(好ましくは炭
素原子数1〜4、例えばメチル、エチル、プロピル)、
アルコキシ基(好ましくは炭素原子数1〜4、例えばメ
トキシ、エトキシ、ブトキシ)、ハロゲン原子(例えば
フッ素原子、塩素原子)、置換アルキル基(好ましくは
炭素原子数1〜4、例えばトリフロロメチル、カルボキ
シメチル)を表わす。R 3 is a hydrogen atom, a lower alkyl group (preferably having 1 to 4 carbon atoms, for example, methyl, ethyl, propyl, butyl), a lower alkoxy group (preferably having 1 to 4 carbon atoms, for example, methoxy, ethoxy, Propoxy, butoxy), a phenyl group, a benzyl group or a phenethyl group. Particularly, a lower alkyl group and a benzyl group are advantageously used. V is a hydrogen atom, a lower alkyl group (preferably having 1 to 4 carbon atoms, for example, methyl, ethyl, propyl),
An alkoxy group (preferably having 1 to 4 carbon atoms, for example, methoxy, ethoxy, butoxy), a halogen atom (for example, fluorine atom, chlorine atom), a substituted alkyl group (preferably having 1 to 4 carbon atoms, for example, trifluoromethyl, carboxy) Methyl).
【0024】Z1 は5員又は6員の含窒素複素環を完成
するに必要な非金属原子群を表わし、例えばチアゾール
核〔例えばベンゾチアゾール、4−クロルベンゾチアゾ
ール、5−クロルベンゾチアゾール、6−クロルベンゾ
チアゾール、7−クロルベンゾチアゾール、4−メチル
ベンゾチアゾール、5−メチルベンゾチアゾール、6−
メチルベンゾチアゾール、5−ブロモベンゾチアゾー
ル、6−ブロモベンゾチアゾール、5−ヨードベンゾチ
アゾール、5−フェニルベンゾチアゾール、5−メトキ
シベンゾチアゾール、6−メトキシベンゾチアゾール、
5−エトキシベンゾチアゾール、5−カルボキシベンゾ
チアゾール、5−エトキシカルボニルベンゾチアゾー
ル、5−フェネチルベンゾチアゾール、5−フルオロベ
ンゾチアゾール、5−トリフルオロメチルベンゾチアゾ
ール、5,6−ジメチルベンゾチアゾール、5−ヒドロ
キシ−6−メチルベンゾチアゾール、テトラヒドロベン
ゾチアゾール、4−フェニルベンゾチアゾール、ナフト
〔2,1−d〕チアゾール、ナフト〔1,2−d〕チア
ゾール、ナフト〔2,3−d〕チアゾール、5−メトキ
シナフト〔1,2−d〕チアゾール、7−エトキシナフ
ト〔2,1−d〕チアゾール、8−メトキシナフト
〔2,1−d〕チアゾール、5−メトキシナフト〔2,
3−d〕チアゾール〕、セレナゾール核〔例えばベンゾ
セレナゾール、5−クロルベンゾセレナゾール、5−メ
トキシベンゾセレナゾール、5−メチルベンゾセレナゾ
ール、5−ヒドロキシベンゾセレナゾール、ナフト
〔2,1−d〕セレナゾール、ナフト〔1,2−d〕セ
レナゾール〕、オキサゾール核〔ベンゾオキサゾール、
5−クロルベンゾオキサゾール、5−メチルベンゾオキ
サゾール、5−ブロムベンゾオキサゾール、5−フルオ
ロベンゾオキサゾール、5−フェニルベンゾオキサゾー
ル、5−メトキシベンゾオキサゾール、5−トリフルオ
ロベンゾオキサゾール、5−ヒドロキシベンゾオキサゾ
ール、5−カルボキシベンゾオキサゾール、6−メチル
ベンゾオキサゾール、6−クロルベンゾオキサゾール、
6−メトキシベンゾオキサゾール、6−ヒドロキシベン
ゾオキサゾール、5,6−ジメチルベンゾオキサゾー
ル、4,6−ジメチルベンゾオキサゾール、5−エトキ
シベンゾオキサゾール、ナフト〔2,1−d〕オキサゾ
ール、ナフト〔1,2−d〕オキサゾール、ナフト
〔2,3−d〕オキサゾール〕、キノリン核〔例えば2
−キノリン、3−メチル−2−キノリン、5−エチル−
2−キノリン、6−メチル−2−キノリン、8−フルオ
ロ−2−キノリン、6−メトキシ−2−キノリン、6−
ヒドロキシ−2−キノリン、8−クロロ−2−キノリ
ン、8−フルオロ−4−キノリン〕、3,3−ジアルキ
ルインドレニン核(例えば、3,3−ジメチルインドレ
ニン、3,3−ジエチルインドレニン、3,3−ジメチ
ル−5−シアノインドレニン、3,3−ジメチル−5−
メトキシインドレニン、3,3−ジメチル−5−メチル
インドレニン、3,3−ジメチル−5−クロルインドレ
ニン)、イミダゾール核(例えば、1−メチルベンゾイ
ミダゾール、1−エチルベンゾイミダゾール、1−メチ
ル−5−クロルベンゾイミダゾール、1−エチル−5−
クロルベンゾイミダゾール、1−メチル−5,6−ジク
ロルベンゾイミダゾール、1−エチル−5,6−ジクロ
ルベンゾイミダゾール、1−エチル−5−メトキシベン
ゾイミダゾール、1−メチル−5−シアノベンゾイミダ
ゾール、1−エチル−5−シアノベンゾイミダゾール、
1−メチル−5−フルオロベンゾイミダゾール、1−エ
チル−5−フルオロベンゾイミダゾール、1−フェニル
−5,6−ジクロルベンゾイミダゾール、1−アリル−
5,6−ジクロルベンゾイミダゾール、1−アリル−5
−クロルベンゾイミダゾール、1−フェニルベンゾイミ
ダゾール、1−フェニル−5−クロルベンゾイミダゾー
ル、1−メチル−5−トリフルオロメチルベンゾイミダ
ゾール、1−エチル−5−トリフルオロメチルベンゾイ
ミダゾール、1−エチルナフト〔1,2−d〕イミダゾ
ール)、ピリジン核(例えばピリジン、5−メチル−2
−ピリジン、3−メチル−4−ピリジン)を挙げること
ができる。これらのうち好ましくはチアゾール核、オキ
サゾール核が有利に用いられる。更に好ましくはベンゾ
チアゾール核、ナフトチアゾール核、ナフトオキサゾー
ル核又はベンゾオキサゾール核が有利に用いられる。
m、pおよびqはそれぞれ独立に1又は2を表わす。但
し色素が分子内塩を形成するときはqは1である。Z 1 represents a group of nonmetallic atoms necessary for completing a 5- or 6-membered nitrogen-containing heterocyclic ring, for example, a thiazole nucleus [for example, benzothiazole, 4-chlorobenzothiazole, 5-chlorobenzothiazole, 6 -Chlorobenzothiazole, 7-chlorobenzothiazole, 4-methylbenzothiazole, 5-methylbenzothiazole, 6-
Methylbenzothiazole, 5-bromobenzothiazole, 6-bromobenzothiazole, 5-iodobenzothiazole, 5-phenylbenzothiazole, 5-methoxybenzothiazole, 6-methoxybenzothiazole,
5-ethoxybenzothiazole, 5-carboxybenzothiazole, 5-ethoxycarbonylbenzothiazole, 5-phenethylbenzothiazole, 5-fluorobenzothiazole, 5-trifluoromethylbenzothiazole, 5,6-dimethylbenzothiazole, 5-hydroxy -6-methylbenzothiazole, tetrahydrobenzothiazole, 4-phenylbenzothiazole, naphtho [2,1-d] thiazole, naphtho [1,2-d] thiazole, naphtho [2,3-d] thiazole, 5-methoxy Naphtho [1,2-d] thiazole, 7-ethoxynaphtho [2,1-d] thiazole, 8-methoxynaphtho [2,1-d] thiazole, 5-methoxynaphtho [2
3-d] thiazole], selenazole nucleus [for example, benzoselenazole, 5-chlorobenzoselenazole, 5-methoxybenzoselenazole, 5-methylbenzoselenazole, 5-hydroxybenzoselenazole, naphtho [2,1-d ] Selenazole, naphtho [1,2-d] selenazole], oxazole nucleus [benzoxazole,
5-chlorobenzoxazole, 5-methylbenzoxazole, 5-bromobenzoxazole, 5-fluorobenzoxazole, 5-phenylbenzoxazole, 5-methoxybenzoxazole, 5-trifluorobenzoxazole, 5-hydroxybenzoxazole, 5 -Carboxybenzoxazole, 6-methylbenzoxazole, 6-chlorobenzoxazole,
6-methoxybenzoxazole, 6-hydroxybenzoxazole, 5,6-dimethylbenzoxazole, 4,6-dimethylbenzoxazole, 5-ethoxybenzoxazole, naphtho [2,1-d] oxazole, naphtho [1,2- d] oxazole, naphtho [2,3-d] oxazole], quinoline nucleus [for example, 2
-Quinoline, 3-methyl-2-quinoline, 5-ethyl-
2-quinoline, 6-methyl-2-quinoline, 8-fluoro-2-quinoline, 6-methoxy-2-quinoline, 6-
Hydroxy-2-quinoline, 8-chloro-2-quinoline, 8-fluoro-4-quinoline], a 3,3-dialkylindolenine nucleus (for example, 3,3-dimethylindolenine, 3,3-diethylindolenine, 3,3-dimethyl-5-cyanoindolenine, 3,3-dimethyl-5-
Methoxyindolenine, 3,3-dimethyl-5-methylindolenine, 3,3-dimethyl-5-chloroindolenine), imidazole nucleus (for example, 1-methylbenzimidazole, 1-ethylbenzimidazole, 1-methyl- 5-chlorobenzimidazole, 1-ethyl-5-
Chlorobenzimidazole, 1-methyl-5,6-dichlorobenzimidazole, 1-ethyl-5,6-dichlorobenzimidazole, 1-ethyl-5-methoxybenzimidazole, 1-methyl-5-cyanobenzimidazole, 1-ethyl-5-cyanobenzimidazole,
1-methyl-5-fluorobenzimidazole, 1-ethyl-5-fluorobenzimidazole, 1-phenyl-5,6-dichlorobenzimidazole, 1-allyl-
5,6-dichlorobenzimidazole, 1-allyl-5
-Chlorobenzimidazole, 1-phenylbenzimidazole, 1-phenyl-5-chlorobenzimidazole, 1-methyl-5-trifluoromethylbenzimidazole, 1-ethyl-5-trifluoromethylbenzimidazole, 1-ethylnaphtho [1 , 2-d] imidazole), a pyridine nucleus (eg, pyridine, 5-methyl-2)
-Pyridine, 3-methyl-4-pyridine). Of these, thiazole nuclei and oxazole nuclei are preferably used advantageously. More preferably, a benzothiazole nucleus, a naphthothiazole nucleus, a naphthoxazole nucleus or a benzoxazole nucleus is advantageously used.
m, p and q each independently represent 1 or 2. However, q is 1 when the dye forms an inner salt.
【0025】X1 は酸アニオン(例えばクロリド、ブロ
ミド、ヨージド、テトラフルオロボラード、ヘキサフル
オロホスファート、メチルスルファート、エチルスルフ
ァート、ベンゼンスルホナート、4−メチルベンゼンス
ルホナート、4−クロロベンゼンスルホナート、4−ニ
トロベンゼンスルホナート、トリフルオロメタンスルホ
ナート、パークロラート)を表わす。X 1 is an acid anion (for example, chloride, bromide, iodide, tetrafluoroborate, hexafluorophosphate, methyl sulfate, ethyl sulfate, benzenesulfonate, 4-methylbenzenesulfonate, 4-chlorobenzenesulfonate, 4-nitrobenzenesulfonate, trifluoromethanesulfonate, perchlorate).
【0026】[0026]
【化7】 Embedded image
【0027】式中、R1 ′及びR2 ′は各々同一であっ
ても異っていてもよく、それぞれアルキル基(置換アル
キル基をふくむ)を表わす。好ましくは炭素原子数1〜
8。例えばメチル、エチル、プロピル、ブチル、ペンチ
ル、ヘプチル、オクチル。置換基としては例えばカルボ
キシル基、スルホ基、シアノ基、ハロゲン原子(例えば
フッ素原子、塩素原子、臭素原子)、ヒドロキシル基、
アルコキシカルボニル基(好ましくは、炭素原子数8以
下、例えばメトキシカルボニル、エトキシカルボニル、
ベンジルオキシカルボニルなど)、アルコキシ基(好ま
しくは炭素原子数7以下、例えばメトキシ、エトキシ、
プロポキシ、ブトキシ、ベンジルオキシ)、アリールオ
キシ基(例えばフェノキシ、p−トリルオキシ)、アシ
ルオキシ基(好ましくは炭素原子数3以下、例えばアセ
チルオキシ、プロピオニルオキシ)、アシル基(好まし
くは炭素原子数8以下、例えばアセチル、プロピオニ
ル、ベンゾイル、メシル)、カルバモイル基(例えばカ
ルバモイル、N,N−ジメチルカルバモイル、モルホリ
ノカルバモイル、ピペリジノカルバモイル)、スルファ
モイル基(例えばスルファモイル、N,N−ジメチルス
ルファモイル、モルホリノスルホニル)、アリール基
(例えばフェニル、p−ヒドロキシフェニル、p−カル
ボキシフェニル、p−スルホフェニル、α−ナフチル)
などで置換されたアルキル基(好ましくはアルキル部分
の炭素原子数6以下)が挙げられる。但し、この置換基
は2つ以上組合せてアルキル基に置換されてよい。In the formula, R 1 ′ and R 2 ′ may be the same or different and each represents an alkyl group (including a substituted alkyl group). Preferably 1 to 1 carbon atoms
8. For example, methyl, ethyl, propyl, butyl, pentyl, heptyl, octyl. Examples of the substituent include a carboxyl group, a sulfo group, a cyano group, a halogen atom (eg, a fluorine atom, a chlorine atom, and a bromine atom), a hydroxyl group,
Alkoxycarbonyl group (preferably having 8 or less carbon atoms, for example, methoxycarbonyl, ethoxycarbonyl,
Benzyloxycarbonyl, etc.), an alkoxy group (preferably having 7 or less carbon atoms, for example, methoxy, ethoxy,
Propoxy, butoxy, benzyloxy), an aryloxy group (eg, phenoxy, p-tolyloxy), an acyloxy group (preferably having 3 or less carbon atoms, for example, acetyloxy, propionyloxy), an acyl group (preferably having 8 or less carbon atoms, For example, acetyl, propionyl, benzoyl, mesyl), carbamoyl group (for example, carbamoyl, N, N-dimethylcarbamoyl, morpholinocarbamoyl, piperidinocarbamoyl), sulfamoyl group (for example, sulfamoyl, N, N-dimethylsulfamoyl, morpholinosulfonyl) An aryl group (eg, phenyl, p-hydroxyphenyl, p-carboxyphenyl, p-sulfophenyl, α-naphthyl)
And the like (preferably having 6 or less carbon atoms in the alkyl portion). However, two or more of these substituents may be substituted with an alkyl group.
【0028】R3 ′、R4 ′は水素原子、低級アルキル
基(好ましくは炭素原子数1〜4、例えばメチル、エチ
ル、プロピル、ブチル)、低級アルコキシ基(好ましく
は炭素原子数1〜4、例えばメトキシ、エトキシ、プロ
ポキシ、ブトキシ)、フェニル基、ベンジル基又はフェ
ネチル基を表わす。特に低級アルキル基、ベンジル基が
有利に用いられる。R5 ′及びR6 ′はそれぞれ水素原
子を表わすか、又はR5 ′とR6 ′とが連結して2価の
アルキレン基(例えばエチレン又はトリメチレン)を形
成する。このアルキレン基は1個、2個又はそれ以上の
適当な基、例えばアルキル基(好ましくは炭素原子数1
〜4、例えばメチル、エチル、プロピル、イソプロピ
ル、ブチル)、ハロゲン原子(例えば塩素原子、臭素原
子)、あるいはアルコキシ基(好ましくは炭素原子数1
〜4、例えばメトキシ、エトキシ、プロポキシ、イソプ
ロポキシ、ブトキシ)などで置換されていてもよい。R
7 ′は水素原子、低級アルキル基(好ましくは炭素原子
数1〜4、例えばメチル、エチル、プロピルなど)、低
級アルコキシ基(好ましくは炭素原子数1〜4、例えば
メトキシ、エトキシ、プロポキシ、ブトキシなど)、フ
ェニル、ベンジル基、又は−N(W1 ′)(W2 ′)を
表わす。ここでW1 ′とW2 ′は各々独立にアルキル基
(置換アルキル基を含む。好ましくはアルキル部分の炭
素原子数1〜18、更に好ましくは1〜4、例えばメチ
ル、エチル、プロピル、ブチル、ベンジル、フェニルエ
チル)、又はアリール基(置換フェニル基を含む。例え
ばフェニル、ナフチル、トリル、p−クロロフェニルな
ど)を表わし、W1 ′とW2 ′とは互いに連結して5員
又は6員の含窒素複素環を形成することもできる。但
し、R3 ′とR7 ′またはR4 ′とR7 ′とが連結して
2価のアルキレン基(前記R5 ′とR6 ′とが連結して
形成する2価のアルキレン基と同義)を形成することも
できる。R 3 ′ and R 4 ′ are a hydrogen atom, a lower alkyl group (preferably having 1 to 4 carbon atoms, for example, methyl, ethyl, propyl, butyl) and a lower alkoxy group (preferably having 1 to 4 carbon atoms; For example, methoxy, ethoxy, propoxy, butoxy), phenyl, benzyl or phenethyl. Particularly, a lower alkyl group and a benzyl group are advantageously used. R 5 ′ and R 6 ′ each represent a hydrogen atom, or R 5 ′ and R 6 ′ are linked to form a divalent alkylene group (for example, ethylene or trimethylene). The alkylene group may be one, two or more suitable groups, such as an alkyl group (preferably having 1 carbon atom).
To 4, for example, methyl, ethyl, propyl, isopropyl, butyl), a halogen atom (for example, a chlorine atom or a bromine atom), or an alkoxy group (preferably having 1 carbon atom)
-4, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy) and the like. R
7 'is a hydrogen atom, a lower alkyl group (preferably having 1 to 4 carbon atoms, for example, methyl, ethyl, propyl, etc.), a lower alkoxy group (preferably having 1 to 4 carbon atoms, for example, methoxy, ethoxy, propoxy, butoxy, etc.) ), represents phenyl, benzyl, or -N a (W 1 ') (W 2 '). Here, W 1 ′ and W 2 ′ each independently represent an alkyl group (including a substituted alkyl group. Preferably, the alkyl moiety has 1 to 18 carbon atoms, more preferably 1 to 4 carbon atoms, for example, methyl, ethyl, propyl, butyl, Benzyl, phenylethyl) or an aryl group (including a substituted phenyl group; for example, phenyl, naphthyl, tolyl, p-chlorophenyl, etc.), and W 1 ′ and W 2 ′ are linked to each other to form a 5- or 6-membered group. It can also form a nitrogen-containing heterocycle. Provided that R 3 ′ and R 7 ′ or R 4 ′ and R 7 ′ are linked to each other to form a divalent alkylene group (synonymous with the aforementioned divalent alkylene group formed by linking R 5 ′ to R 6 ′) ) Can also be formed.
【0029】Z′およびZ1 ′は5員又は6員の含窒素
複素環を完成するに必要な非金属原子群を表わし、例え
ばチアゾール核〔例えばベンゾチアゾール、4−クロル
ベンゾチアゾール、5−クロルベンゾチアゾール、6−
クロルベンゾチアゾール、7−クロルベンゾチアゾー
ル、4−メチルベンゾチアゾール、5−メチルベンゾチ
アゾール、6−メチルベンゾチアゾール、5−ブロモベ
ンゾチアゾール、6−ブロモベンゾチアゾール、5−ヨ
ードベンゾチアゾール、5−フェニルベンゾチアゾー
ル、5−メトキシベンゾチアゾール、6−メトキシベン
ゾチアゾール、5−エトキシベンゾチアゾール、5−カ
ルボキシベンゾチアゾール、5−エトキシカルボニルベ
ンゾチアゾール、5−フェネチルベンゾチアゾール、5
−フルオロベンゾチアゾール、5−トリフルオロメチル
ベンゾチアゾール、5,6−ジメチルベンゾチアゾー
ル、5−ヒドロキシ−6−メチルベンゾチアゾール、テ
トラヒドロベンゾチアゾール、4−フェニルベンゾチア
ゾール、ナフト〔2,1−d〕チアゾール、ナフト
〔1,2−d〕チアゾール、ナフト〔2,3−d〕チア
ゾール、5−メトキシナフト〔1,2−d〕チアゾー
ル、7−エトキシナフト〔2,1−d〕チアゾール、8
−メトキシナフト〔2,1−d〕チアゾール、5−メト
キシナフト〔2,3−d〕チアゾール〕、セレナゾール
核〔例えばベンゾセレナゾール、5−クロルベンゾセレ
ナゾール、5−メトキシベンゾセレナゾール、5−メチ
ルベンゾセレナゾール、5−ヒドロキシベンゾセレナゾ
ール、ナフト〔2,1−d〕セレナゾール、ナフト
〔1,2−d〕セレナゾール〕、オキサゾール核〔ベン
ゾオキサゾール、5−クロルベンゾオキサゾール、5−
メチルベンゾオキサゾール、5−ブロムベンゾオキサゾ
ール、5−フルオロベンゾオキサゾール、5−フェニル
ベンゾオキサゾール、5−メトキシベンゾオキサゾー
ル、5−トリフルオロベンゾオキサゾール、5−ヒドロ
キシベンゾオキサゾール、5−カルボキシベンゾオキサ
ゾール、6−メチルベンゾオキサゾール、6−クロルベ
ンゾオキサゾール、6−メトキシベンゾオキサゾール、
6−ヒドロキシベンゾオキサゾール、5,6−ジメチル
ベンゾオキサゾール、4,6−ジメチルベンゾオキサゾ
ール、5−エトキシベンゾオキサゾール、ナフト〔2,
1−d〕オキサゾール、ナフト〔1,2−d〕オキサゾ
ール、ナフト〔2,3−d〕オキサゾール〕、キノリン
核〔例えば2−キノリン、3−メチル−2−キノリン、
5−エチル−2−キノリン、6−メチル−2−キノリ
ン、8−フルオロ−2−キノリン、6−メトキシ−2−
キノリン、6−ヒドロキシ−2−キノリン、8−クロロ
−2−キノリン、8−フルオロ−4−キノリン〕、3,
3−ジアルキルインドレニン核(例えば、3,3−ジメ
チルインドレニン、3,3−ジエチルインドレニン、
3,3−ジメチル−5−ジアノインドレニン、3,3−
ジメチル−5−メトキシインドレニン、3,3−ジメチ
ル−5−メチルインドレニン、3,3−ジメチル−5−
クロルインドレニン)、イミダゾール核(例えば、1−
メチルベンゾイミダゾール、1−エチルベンゾイミダゾ
ール、1−メチル−5−クロルベンゾイミダゾール、1
−エチル−5−クロルベンゾイミダゾール、1−メチル
−5,6−ジクロルベンゾイミダゾール、1−エチル−
5,6−ジクロルベンゾイミダゾール、1−エチル−5
−メトキシベンゾイミダゾール、1−メチル−5−シア
ノベンゾイミダゾール、1−エチル−5−シアノベンゾ
イミダゾール、1−メチル−5−フルオロベンゾイミダ
ゾール、1−エチル−5−フルオロベンゾイミダゾー
ル、1−フェニル−5,6−ジクロルベンゾイミダゾー
ル、1−アリル−5,6−ジクロルベンゾイミダゾー
ル、1−アリル−5−クロルベンゾイミダゾール、1−
フェニルベンゾイミダゾール、1−フェニル−5−クロ
ルベンゾイミダゾール、1−メチル−5−トリフルオロ
メチルベンゾイミダゾール、1−エチル−5−トリフル
オロメチルベンゾイミダゾール、1−エチルナフト
〔1,2−d〕イミダゾール)、ピリジン核(例えばピ
リジン、5−メチル−2−ピリジン、3−メチル−4−
ピリジン)を挙げることができる。これらのうち好まし
くはチアゾール核、オキサゾール核が有利に用いられ
る。更に好ましくはベンゾチアゾール核、ナフトチアゾ
ール核、ナフトオキサゾール核又はベンゾオキサゾール
核が有利に用いられる。Z ′ and Z 1 ′ represent a group of nonmetal atoms necessary to complete a 5- or 6-membered nitrogen-containing heterocyclic ring, for example, a thiazole nucleus [for example, benzothiazole, 4-chlorobenzothiazole, 5-chloro] Benzothiazole, 6-
Chlorobenzothiazole, 7-chlorobenzothiazole, 4-methylbenzothiazole, 5-methylbenzothiazole, 6-methylbenzothiazole, 5-bromobenzothiazole, 6-bromobenzothiazole, 5-iodobenzothiazole, 5-phenylbenzo Thiazole, 5-methoxybenzothiazole, 6-methoxybenzothiazole, 5-ethoxybenzothiazole, 5-carboxybenzothiazole, 5-ethoxycarbonylbenzothiazole, 5-phenethylbenzothiazole, 5
-Fluorobenzothiazole, 5-trifluoromethylbenzothiazole, 5,6-dimethylbenzothiazole, 5-hydroxy-6-methylbenzothiazole, tetrahydrobenzothiazole, 4-phenylbenzothiazole, naphtho [2,1-d] thiazole , Naphtho [1,2-d] thiazole, naphtho [2,3-d] thiazole, 5-methoxynaphtho [1,2-d] thiazole, 7-ethoxynaphtho [2,1-d] thiazole, 8
-Methoxynaphtho [2,1-d] thiazole, 5-methoxynaphtho [2,3-d] thiazole], a selenazole nucleus [for example, benzoselenazole, 5-chlorobenzoselenazole, 5-methoxybenzoselenazole, 5- Methylbenzoselenazole, 5-hydroxybenzoselenazole, naphtho [2,1-d] selenazole, naphtho [1,2-d] selenazole], oxazole nucleus [benzoxazole, 5-chlorobenzoxazole, 5-
Methyl benzoxazole, 5-bromobenzoxazole, 5-fluorobenzoxazole, 5-phenylbenzoxazole, 5-methoxybenzoxazole, 5-trifluorobenzoxazole, 5-hydroxybenzoxazole, 5-carboxybenzoxazole, 6-methyl Benzoxazole, 6-chlorobenzoxazole, 6-methoxybenzoxazole,
6-hydroxybenzoxazole, 5,6-dimethylbenzoxazole, 4,6-dimethylbenzoxazole, 5-ethoxybenzoxazole, naphtho [2,
1-d] oxazole, naphtho [1,2-d] oxazole, naphtho [2,3-d] oxazole], quinoline nucleus [for example, 2-quinoline, 3-methyl-2-quinoline,
5-ethyl-2-quinoline, 6-methyl-2-quinoline, 8-fluoro-2-quinoline, 6-methoxy-2-
Quinoline, 6-hydroxy-2-quinoline, 8-chloro-2-quinoline, 8-fluoro-4-quinoline], 3,
3-dialkylindolenine nucleus (for example, 3,3-dimethylindolenine, 3,3-diethylindolenine,
3,3-dimethyl-5-dianoindolenine, 3,3-
Dimethyl-5-methoxyindolenine, 3,3-dimethyl-5-methylindolenine, 3,3-dimethyl-5-
Chlorindolenine), imidazole nucleus (for example, 1-
Methylbenzimidazole, 1-ethylbenzimidazole, 1-methyl-5-chlorobenzimidazole, 1
-Ethyl-5-chlorobenzimidazole, 1-methyl-5,6-dichlorobenzimidazole, 1-ethyl-
5,6-dichlorobenzimidazole, 1-ethyl-5
-Methoxybenzimidazole, 1-methyl-5-cyanobenzimidazole, 1-ethyl-5-cyanobenzimidazole, 1-methyl-5-fluorobenzimidazole, 1-ethyl-5-fluorobenzimidazole, 1-phenyl-5 , 6-Dichlorobenzimidazole, 1-allyl-5,6-dichlorobenzimidazole, 1-allyl-5-chlorobenzimidazole, 1-
Phenylbenzimidazole, 1-phenyl-5-chlorobenzimidazole, 1-methyl-5-trifluoromethylbenzimidazole, 1-ethyl-5-trifluoromethylbenzimidazole, 1-ethylnaphtho [1,2-d] imidazole) , A pyridine nucleus (for example, pyridine, 5-methyl-2-pyridine, 3-methyl-4-
Pyridine). Of these, thiazole nuclei and oxazole nuclei are preferably used advantageously. More preferably, a benzothiazole nucleus, a naphthothiazole nucleus, a naphthoxazole nucleus or a benzoxazole nucleus is advantageously used.
【0030】X1 ′は酸アニオン(例えばクロリド、ブ
ロミド、ヨージド、テトラフルオロボラード、ヘキサフ
ルオロホスファート、メチルスルファート、エチルスル
ファート、ベンゼンスルホナート、4−メチルベンゼン
スルホナート、4−クロロベンゼンスルホナート、4−
ニトロベンゼンスルホナート、トリフルオロメタンスル
ホナート、パークロラート)を表わす。m′は0または
1を表わし、色素が分子内塩を形成するときは1であ
る。X 1 'is an acid anion (for example, chloride, bromide, iodide, tetrafluoroborate, hexafluorophosphate, methyl sulfate, ethyl sulfate, benzene sulfonate, 4-methylbenzene sulfonate, 4-chlorobenzene sulfonate , 4-
Nitrobenzenesulfonate, trifluoromethanesulfonate, perchlorate). m 'represents 0 or 1, and is 1 when the dye forms an inner salt.
【0031】具体的化合物例を以下に示す。ただし本発
明はこれらのみに限定されるものではない。Specific examples of the compounds are shown below. However, the present invention is not limited only to these.
【0032】[0032]
【化8】 Embedded image
【0033】[0033]
【化9】 Embedded image
【0034】[0034]
【化10】 Embedded image
【0035】[0035]
【化11】 Embedded image
【0036】[0036]
【化12】 Embedded image
【0037】[0037]
【化13】 Embedded image
【0038】[0038]
【化14】 Embedded image
【0039】[0039]
【化15】 Embedded image
【0040】[0040]
【化16】 Embedded image
【0041】これらの増感色素は単独に用いてもよい
が、それらの組合せを用いてもよく、増感色素の組合せ
は特に、強色増感の目的でしばしば用いられる。増感色
素とともに、それ自身分光増感作用をもたない色素ある
いは可視光を実質的に吸収しない物質であって、強色増
感を示す物質を乳剤中に含んでもよい。有用な増感色
素、強色増感を示す色素の組合せ及び強色増感を示す物
質はリサーチ・ディスクロージャ(Research Disclosur
e)176巻17643(1978年12月発行)第23
頁IVのJ項、あるいは前述の特公昭49−25500、
同43−4933、特開昭59−19032、同59−
192242等に記載されている。本発明の増感色素の
含有量はハロゲン化銀乳剤の粒子径、ハロゲン組成、化
学増感の方法と程度、該化合物を含有させる層とハロゲ
ン化銀乳剤の関係、カブリ防止化合物の種類などに応じ
て最適の量を選択することが望ましく、その選択のため
の試験の方法は当業者のよく知るところである。通常は
好ましくはハロゲン化銀1モル当り10-7モルないし1
×10-2モル、特に10-6ないし5×10-3モルの範囲
で用いられる。These sensitizing dyes may be used alone or in combination, and the combination of sensitizing dyes is often used particularly for supersensitization. Along with the sensitizing dye, the emulsion may contain a dye which does not itself have a spectral sensitizing effect or a substance which does not substantially absorb visible light and exhibits supersensitization. Useful sensitizing dyes, combinations of dyes exhibiting supersensitization, and substances exhibiting supersensitization are described in Research Disclosur.
e) Vol. 176, Volume 17643 (December 1978) No. 23
Section IV on page IV, or the aforementioned JP-B-49-25500,
43-4933, JP-A-59-19032, and 59-19032.
192242. The content of the sensitizing dye of the present invention depends on the grain size of the silver halide emulsion, the halogen composition, the method and degree of chemical sensitization, the relationship between the layer containing the compound and the silver halide emulsion, the type of antifoggant compound, and the like. It is desirable to select the optimal amount accordingly, and the methods of testing for that selection are well known to those skilled in the art. Usually, it is preferably from 10 -7 mol to 1 mol per mol of silver halide.
It is used in the range of 10-2 mol, especially 10-6 to 5 10-3 mol.
【0042】また、これらの一般式で示される赤外増感
色素は、特開昭59−192242号あるいは米国特許
3,482,978号、同2,756,227号等の方
法で合成することができる。前記の一般式をもつ増感色
素は、特に赤外域の増感特性が優れているので好まし
い。本発明においては、更に次の一般式の化合物を組合
せて用いることができる。The infrared sensitizing dyes represented by these general formulas can be synthesized by the method described in JP-A-59-192242 or US Pat. Nos. 3,482,978 and 2,756,227. Can be. Sensitizing dyes having the above general formula are preferred because they have particularly good sensitizing properties in the infrared region. In the present invention, compounds of the following general formulas can be used in combination.
【0043】[0043]
【化17】 Embedded image
【0044】式中Z3 は5員又は6員の含窒素複素環を
完成するに必要な非金属原子群を表わし、例えばチアゾ
リウム類{例えばチアゾリウム、4−メチルチアゾリウ
ム、ベンゾチアゾリウム、5−メチルベンゾチアゾリウ
ム、5−クロロベンゾチアゾリウム、5−メトキシベン
ゾチアゾリウム、6−メチルベンゾチアゾリウム、6−
メトキシベンゾチアゾリウム、ナフト〔1,2−d〕チ
アゾリウム、ナフト〔2,1−d〕チアゾリウムな
ど}、オキサゾリウム類{例えばオキサゾリウム、4−
メチルオキサゾリウム、ベンゾオキサゾリウム、5−ク
ロロベンゾオキサゾリウム、5−フェニルベンゾオキサ
ゾリウム、5−メチルベンゾオキサゾリウム、ナフト
〔1,2−d〕オキサゾリウムなど}、イミダゾリウム
類(例えば1−メチルベンツイミダゾリウム、1−プロ
ピル−5−クロロベンツイミダゾリウム、1−エチル−
5,6−ジクロロベンツイミダゾリウム、1−アリル−
5−トリクロロメチル−6−クロロ−ベンツイミダゾリ
ウムなど)、セレナゾリウム類〔例えばベンゾセレナゾ
リウム、5−クロロベンゾセレナゾリウム、5−メチル
ベンゾセレナゾリウム、5−メトキシベンゾセレナゾリ
ウム、ナフト〔1,2−d〕セレナゾリウムなど〕を表
す。R13は水素原子、アルキル基(炭素原子数8以下、
例えばメチル基、エチル基、プロピル基、ブチル基、ペ
ンチル基など)、アルケニル基(例えばアリル基など)
を表す。R14は水素原子、低級アルキル基(例えばメチ
ル基、エチル基など)を表す。X2 は酸アニオン(例え
ばCl- 、Br- 、I- 、ClO4 - 、p−トルエンス
ルホン酸など)、Z3 の中で好ましくはチアゾリウム類
が有利に用いられる。更に好ましくは置換又は無置換の
ベンゾチアゾリウム又はナフトチアゾリウムが有利に用
いられる。化合物の具体例をいかに示す。しかし本発明
はこれらの化合物のみに限定されるものではない。In the formula, Z 3 represents a group of non-metallic atoms necessary for completing a 5- or 6-membered nitrogen-containing heterocyclic ring, for example, thiazoliums such as thiazolium, 4-methylthiazolium, benzothiazolium, 5-methylbenzothiazolium, 5-chlorobenzothiazolium, 5-methoxybenzothiazolium, 6-methylbenzothiazolium, 6-methylbenzothiazolium
Methoxybenzothiazolium, naphtho [1,2-d] thiazolium, naphtho [2,1-d] thiazolium, etc., oxazoliums {eg oxazolium, 4-
Methylimoxazolium, benzoxazolium, 5-chlorobenzoxazolium, 5-phenylbenzoxazolium, 5-methylbenzoxazolium, naphtho [1,2-d] oxazolium, etc., imidazolium ( For example, 1-methylbenzimidazolium, 1-propyl-5-chlorobenzimidazolium, 1-ethyl-
5,6-dichlorobenzimidazolium, 1-allyl-
5-trichloromethyl-6-chloro-benzimidazolium, etc.), selenazoliums [for example, benzoselenazolium, 5-chlorobenzoselenazolium, 5-methylbenzoselenazolium, 5-methoxybenzoselenazolium, naphtho [ 1,2-d] selenazolium etc.]. R 13 is a hydrogen atom, an alkyl group (having 8 or less carbon atoms,
For example, methyl group, ethyl group, propyl group, butyl group, pentyl group, etc., alkenyl group (eg, allyl group)
Represents R 14 represents a hydrogen atom or a lower alkyl group (eg, a methyl group, an ethyl group, etc.). X 2 is an acid anion (eg, Cl − , Br − , I − , ClO 4 − , p-toluenesulfonic acid, etc.), and Z 3 is preferably a thiazolium. More preferably, substituted or unsubstituted benzothiazolium or naphthothiazolium is advantageously used. Specific examples of the compounds are shown below. However, the present invention is not limited to only these compounds.
【0045】[0045]
【化18】 Embedded image
【0046】[0046]
【化19】 Embedded image
【0047】[0047]
【化20】 Embedded image
【0048】[0048]
【化21】 Embedded image
【0049】上記化合物は、乳剤中のハロゲン化銀1モ
ル当り約0.01グラムから5グラムの量で有利に用い
られる。前述した本発明の赤外増感色素と、上記化合物
との比率(重量比)は、本発明の赤外増感色素/上記化
合物=1/1〜1/300の範囲が有利に用いられ、と
くに1/2〜1/50の範囲が有利に用いられる。本発
明で用いられる上記化合物は、直接乳剤中に分散するこ
とができるし、また適当な溶媒(例えば水、メチルアル
コール、エチルアルコール、プロパノール、メチルセロ
ソルブ、アセトンなど)あるいはこれらの溶媒を複数用
いた混合溶媒中に溶解し、乳剤中へ添加することもでき
る。その他増感色素の添加方法に準じて溶液あるいはコ
ロイド中への分散物の形で乳剤中へ添加することができ
る。上記化合物は、前述した本発明の赤外増感色素の添
加よりも先に乳剤中へ添加されてもよいし、あとに添加
されてもよい。また上記化合物と赤外増感色素とを別々
に溶解し、これらを別々に同時に乳剤中へ添加してもよ
いし、混合したのち乳剤中へ添加してもよい。本発明の
組合せに、更に下記の一般式を有する化合物を加えるこ
とができる。The above compounds are advantageously used in an amount of about 0.01 to 5 grams per mole of silver halide in the emulsion. The ratio (weight ratio) of the above-mentioned infrared sensitizing dye of the present invention to the above compound is advantageously in the range of the infrared sensitizing dye of the present invention / the above compound = 1/1 to 1/300, In particular, the range of 1/2 to 1/50 is advantageously used. The above compound used in the present invention can be directly dispersed in the emulsion, or a suitable solvent (eg, water, methyl alcohol, ethyl alcohol, propanol, methyl cellosolve, acetone, etc.) or a mixture of these solvents is used. It can be dissolved in a mixed solvent and added to the emulsion. The sensitizing dye can be added to the emulsion in the form of a solution or a dispersion in a colloid according to the method of adding the sensitizing dye. The above compound may be added to the emulsion before the addition of the infrared sensitizing dye of the present invention described above, or may be added later. Further, the above compound and the infrared sensitizing dye may be separately dissolved, and these may be separately and simultaneously added to the emulsion, or may be mixed and then added to the emulsion. Compounds having the following general formula can further be added to the combinations according to the invention.
【0050】[0050]
【化22】 Embedded image
【0051】式中、−A−は2価の芳香族残基を表わ
し、これらは−SO3M基〔但しMは水素原子又は水溶
性を与えるカチオン(例えばナトリウム、カリウムな
ど)を表す。〕を含んでいてもよい。−A−は、例えば
次の−A1 −または−A2 −から選ばれたものが有用で
ある。但しR21、R22、R23又はR24に−SO3 Mが含
まれないときは、−A−は−A1 −の群の中から選ばれ
る。In the formula, -A- represents a divalent aromatic residue, and these are -SO 3 M groups, wherein M represents a hydrogen atom or a cation that imparts water solubility (eg, sodium, potassium, etc.). ] May be included. As -A-, for example, those selected from the following -A 1 -or -A 2- are useful. However R 21, R 22, when the R 23 or R 24 do not contain -SO 3 M is, -A- is -A 1 - is selected from the group consisting of.
【0052】[0052]
【化23】 Embedded image
【0053】[0053]
【化24】 Embedded image
【0054】[0054]
【化25】 Embedded image
【0055】R21、R22、R23及びR24は各々水素原
子、ヒドロキシ基、低級アルキル基(炭素原子数として
は1〜8が好ましい、例えばメチル基、エチル基、n−
プロピル基、n−ブチル基など)、アルコキシ基(炭素
原子数としては1〜8が好ましい。例えばメトキシ基、
エトキシ基、プロポキシ基、ブトキシ基など)、アリー
ロキシ基(例えばフェノキシ基、ナフトキシ基、o−ト
ロキシ基、p−スルホフェノキシ基など)、ハロゲン原
子(例えば塩素原子、臭素原子など)、ヘテロ環核(例
えばモルホリニル基、ピペリジル基など)、アルキルチ
オ基(例えばメチルチオ基、エチルチオ基など)、ヘテ
ロシクリルチオ基(例えばベンゾチアゾリルチオ基、ベ
ンゾイミダゾリルチオ基、フェニルテトラゾリルチオ基
など)、アリールチオ基(例えばフェニルチオ基、トリ
ルチオ基)、アミノ基、アルキルアミノ基あるいは置換
アルキルアミノ基(例えばメチルアミノ基、エチルアミ
ノ基、プロピルアミノ基、ジメチルアミノ基、ジエチル
アミノ基、ドデシルアミノ基、シクロヘキシルアミノ
基、β−ヒドロキシエチルアミノ基、ジ−(β−ヒドロ
キシエチル)アミノ基、β−スルホエチルアミノ基)、
アリールアミノ基、または置換アリールアミノ基(例え
ばアニリノ基、o−スルホアニリノ基、m−スルホアニ
リノ基、p−スルホアニリノ基、o−トルイジノ基、m
−トルイジノ基、p−トルイジノ基、o−カルボキシア
ニリノ基、m−カルボキシアニリノ基、p−カルボキシ
アニリノ基、o−クロロアニリノ基、m−クロロアニリ
ノ基、p−クロロアニリノ基、p−アミノアニリノ基、
o−アニシジノ基、m−アニシジノ基、p−アニシジノ
基、o−アセタミノアニリノ基、ヒドロキシアニリノ
基、ジスルホフェニルアミノ基、ナフチルアミノ基、ス
ルホナフチルアミノ基など)、ヘテロシクリルアミノ基
(例えば2−ベンゾチアゾリルアミノ基、2−ピリジル
−アミノ基など)、置換又は無置換のアラルキルアミノ
基(例えばベンジルアミノ基、o−アニシルアミノ基、
m−アニシルアミノ基、p−アニシルアミノ基など)、
アリール基(例えばフェニル基など)、メルカプト基を
表わす。R21、R22、R23、R24は各々互いに同じでも
異なっていてもよい。−A−が−A2 −の群から選ばれ
るときは、R21、R22、R23、R24のうち少なくとも1
つは1つ以上のスルホ基(遊離酸基でもよく、塩を形成
してもよい)を有していることが必要である。W3 及び
W4 は−CH=又は−N=を表わし、少なくともいずれ
か一方は−N=である。次に上記化合物の具体例を挙げ
る。但しこれらの化合物にのみ限定されるものではな
い。R 21 , R 22 , R 23 and R 24 each represent a hydrogen atom, a hydroxy group or a lower alkyl group (preferably having 1 to 8 carbon atoms, for example, a methyl group, an ethyl group, an n-
A propyl group, an n-butyl group and the like, an alkoxy group (the number of carbon atoms is preferably 1 to 8. For example, a methoxy group,
Ethoxy group, propoxy group, butoxy group, etc., aryloxy group (eg, phenoxy group, naphthoxy group, o-troxy group, p-sulfophenoxy group, etc.), halogen atom (eg, chlorine atom, bromine atom, etc.), heterocyclic nucleus ( For example, morpholinyl group, piperidyl group, etc., alkylthio group (eg, methylthio group, ethylthio group, etc.), heterocyclylthio group (eg, benzothiazolylthio group, benzimidazolylthio group, phenyltetrazolylthio group, etc.), arylthio group (eg, phenylthio group, etc.) , Tolylthio group), amino group, alkylamino group or substituted alkylamino group (for example, methylamino group, ethylamino group, propylamino group, dimethylamino group, diethylamino group, dodecylamino group, cyclohexylamino group, β-hydroxy Chiruamino group, di - (beta-hydroxyethyl) amino group, beta-sulfoethylamino group),
An arylamino group or a substituted arylamino group (for example, an anilino group, an o-sulfoanilino group, an m-sulfoanilino group, a p-sulfoanilino group, an o-toluidino group,
-Toluidino group, p-toluidino group, o-carboxyanilino group, m-carboxyanilino group, p-carboxyanilino group, o-chloroanilino group, m-chloroanilino group, p-chloroanilino group, p-aminoanilino group,
o-anisidino group, m-anisidino group, p-anisidino group, o-acetaminoanilino group, hydroxyanilino group, disulfophenylamino group, naphthylamino group, sulfonaphthylamino group, etc., heterocyclylamino group ( For example, a 2-benzothiazolylamino group, a 2-pyridyl-amino group and the like, a substituted or unsubstituted aralkylamino group (for example, a benzylamino group, an o-anisylamino group,
m-anisylamino group, p-anisylamino group, etc.),
Represents an aryl group (for example, a phenyl group) or a mercapto group. R 21 , R 22 , R 23 and R 24 may be the same or different from each other. When -A- is selected from the group of -A 2-, at least one of R 21 , R 22 , R 23 and R 24
One must have one or more sulfo groups (which may be free acid groups or may form salts). W 3 and W 4 represents -CH = or -N =, at least one is -N =. Next, specific examples of the above compounds will be given. However, it is not limited only to these compounds.
【0056】(イ)4,4’−ビス〔4,6−ジ(ベン
ゾチアゾリル−2−チオ)ピリミジン−2−イルアミ
ノ〕スチルベン−2,2’−ジスルホン酸ナトリウム塩 (ロ)4,4’−ビス〔4,6−ジ(ベンゾチアゾリル
−2−アミノ)ピリミジン−2−イルアミノ)〕スチル
ベン−2,2’−ジスルホン酸ジナトリウム塩 (ハ)4,4’−ビス〔4,6−ジ(ナフチル−2−オ
キシ)ピリミジン−2−イルアミノ〕スチルベン−2,
2’−ジスルホン酸ジナトリウム塩 (ニ)4,4’−ビス〔4,6−ジ(ナフチル−2−オ
キシ)ピリミジン−2−イルアミノ〕ビベンジル−2,
2’−ジスルホン酸ジナトリウム塩 (ホ)4,4’−ビス(4,6−ジアニリノピリミジン
−2−イルアミノ)スチルベン−2,2’−ジスルホン
酸ジナトリウム塩 (ヘ)4,4’−ビス〔4−クロロ−6−(2−ナフチ
ルオキシ)ピリミジン−2−イルアミノ〕ビフェニル−
2,2’−ジスルホン酸ジナトリウム塩 (ト)4,4’−ビス〔4,6−ジ(1−フェニルテト
ラゾリル−5−チオ)ピリミジン−2−イルアミノ〕ス
チルベン−2,2’−ジスルホン酸ジナトリウム塩(A) Sodium 4,4'-bis [4,6-di (benzothiazolyl-2-thio) pyrimidin-2-ylamino] stilbene-2,2'-disulfonate (b) 4,4'- Bis [4,6-di (benzothiazolyl-2-amino) pyrimidin-2-ylamino)] stilbene-2,2′-disulfonate disodium salt (c) 4,4′-bis [4,6-di (naphthyl) -2-oxy) pyrimidin-2-ylamino] stilbene-2,
2′-disulfonate disodium salt (d) 4,4′-bis [4,6-di (naphthyl-2-oxy) pyrimidin-2-ylamino] bibenzyl-2,
Disodium salt of 2'-disulfonate (e) 4,4'-bis (4,6-dianilinopyrimidin-2-ylamino) stilbene-2,2'-disulfonate disodium salt (f) 4,4'- Bis [4-chloro-6- (2-naphthyloxy) pyrimidin-2-ylamino] biphenyl-
Disodium 2,2'-disulfonate (g) 4,4'-bis [4,6-di (1-phenyltetrazolyl-5-thio) pyrimidin-2-ylamino] stilbene-2,2'- Disulfonate disodium salt
【0057】(チ)4,4’−ビス〔4,6−ジ(ベン
ゾイミダゾリル−2−チオ)ピリミジン−2−イルアミ
ノ〕スチルベン−2,2’−ジスルホン酸ジナトリウム
塩 (リ)4,4’−ビス〔4,6−ジフェノキシピリミジ
ン−2−イルアミノ)スチルベン−2,2’−ジスルホ
ン酸ジナトリウム塩 (ヌ)4,4’−ビス〔4,6−ジフェニルチオピリミ
ジン−2−イルアミノ)スチルベン−2,2’−ジスル
ホン酸ジナトリウム塩 (ル)4,4’−ビス〔4,6−ジメルカプトピリミジ
ン−2−イルアミノ)ビフェニル−2,2’−ジスルホ
ン酸ジナトリウム塩 (ヲ)4,4’−ビス〔4,6−ジアニリノ−トリアジ
ン−2−イルアミノ)スチルベン−2,2’−ジスルホ
ン酸ジナトリウム塩 (ワ)4,4’−ビス(4−アニリノ−6−ヒドロキシ
−トリアジン−2−イルアミノ)スチルベン−2,2’
−ジスルホン酸ジナトリウム塩 (カ)4,4’−ビス〔4−ナフチルアミノ−6−アニ
リノ−トリアジン−2−イルアミノ)スチルベン−2,
2’−ジスルホン酸ジナトリウム塩 (ヨ)4,4’−ビス〔2,6−ジ(2−ナフトキシ)
ピリミジン−4−イルアミノ〕スチルベン−2,2’−
ジスルホン酸 (タ)4,4’−ビス〔2,6−ジ(2−ナフチルアミ
ノ)ピリミジン−4−イルアミノ〕スチルベン−2,
2’−ジスルホン酸ジナトリウム塩 (レ)4,4’−ビス〔2,6−ジアニリノピリミジン
−4−イルアミノ)スチルベン−2,2’−ジスルホン
酸ジナトリウム塩 (ソ)4,4’−ビス〔2−ナフチルアミノ)−6−ア
ニリノピリミジン−4−イルアミノ〕スチルベン−2,
2’−ジスルホン酸 (ツ)4,4’−ビス〔2,6−ジフェノキシピリミジ
ン−4−イルアミノ〕スチルベン−2,2’−ジスルホ
ン酸ジトリエチルアンモニウム塩 (ネ)4,4’−ビス〔2,6−ジ(ベンゾイミダゾリ
ル−2−チオ)ピリミジン−4−イルアミノ〕スチルベ
ン−2,2’−ジスルホン酸ジナトリウム塩(H) 4,4'-bis [4,6-di (benzimidazolyl-2-thio) pyrimidin-2-ylamino] stilbene-2,2'-disulfonate disodium salt -Bis [4,6-diphenoxypyrimidin-2-ylamino) stilbene-2,2'-disulfonic acid disodium salt (nu) 4,4'-bis [4,6-diphenylthiopyrimidin-2-ylamino) stilbene Disodium 2,2'-disulfonate (酸) 4,4'-bis [4,6-dimercaptopyrimidin-2-ylamino) biphenyl-2,2'-disulfonate disodium salt (塩) 4 4'-bis [4,6-dianilino-triazin-2-ylamino) stilbene-2,2'-disulfonate disodium salt (W) 4,4'-bis (4-anilino-6-hydroxy- Triazin-2-ylamino) stilbene-2,2 '
Disodium disulfonate (f) 4,4'-bis [4-naphthylamino-6-anilino-triazin-2-ylamino) stilbene-2,
Disodium salt of 2'-disulfonate (Y) 4,4'-bis [2,6-di (2-naphthoxy)
Pyrimidin-4-ylamino] stilbene-2,2'-
Disulfonic acid (t) 4,4'-bis [2,6-di (2-naphthylamino) pyrimidin-4-ylamino] stilbene-2,
Disodium salt of 2'-disulfonate (レ) 4,4'-bis [2,6-dianilinopyrimidin-4-ylamino) stilbene-2,2'-disulfonate disodium salt (so) 4,4'- Bis [2-naphthylamino) -6-anilinopyrimidin-4-ylamino] stilbene-2,
2'-Disulfonic acid (z) 4,4'-bis [2,6-diphenoxypyrimidin-4-ylamino] stilbene-2,2'-disulfonic acid ditriethylammonium salt (d) 4,4'-bis [ 2,6-di (benzimidazolyl-2-thio) pyrimidin-4-ylamino] stilbene-2,2'-disulfonate disodium salt
【0058】上記一般式で表わされる化合物は公知であ
るか又は公知方法に従い容易に製造することができる。
本発明に用いられる上記化合物はこれらの2種以上の混
合物を用いてもよい。上記化合物は乳剤中のハロゲン化
銀1モル当り約0.01グラムから5グラムの量で有利
に用いられる。赤外増感色素と、上記一般式で表わされ
る化合物との比率(重量比)は、色素/上記化合物=1
/1〜1/200の範囲が有利に用いられ、とくに1/
2〜1/50の範囲が有利に用いられる。本発明に用い
られる上記一般式で表わされる化合物は直接乳剤中へ分
散することができるし、また適当な溶剤(例えばメチル
アルコール、エチルアルコール、メチルセロソルブ、水
など)あるいはこれらの混合溶媒中に溶解して乳剤へ添
加することもできる。その他増感色素の添加方法に準じ
て溶液あるいはコロイド中への分散物の形で乳剤中へ添
加することができる。また特開昭50−80119号公
報に記載の方法で乳剤中へ分散添加することもできる。The compounds represented by the above general formulas are known or can be easily produced according to known methods.
The above compound used in the present invention may be a mixture of two or more of these compounds. The above compounds are advantageously used in an amount of about 0.01 to 5 grams per mole of silver halide in the emulsion. The ratio (weight ratio) of the infrared sensitizing dye to the compound represented by the above general formula is dye / the above compound = 1.
The range of from 1/1 to 1/200 is advantageously used, especially 1/200.
A range of 2 to 1/50 is advantageously used. The compound represented by the above general formula used in the present invention can be directly dispersed in the emulsion or dissolved in an appropriate solvent (eg, methyl alcohol, ethyl alcohol, methyl cellosolve, water, etc.) or a mixed solvent thereof. Can be added to the emulsion. The sensitizing dye can be added to the emulsion in the form of a solution or a dispersion in a colloid according to the method of adding the sensitizing dye. Further, it can be dispersed in an emulsion by the method described in JP-A-50-80119.
【0059】本発明の感光材料には、感光材料の製造工
程、保存中あるいは写真処理中のカブリを防止しあるい
は写真性能を安定化させる目的で、種々の化合物を含有
させることができる。すなわちアゾール類たとえばベン
ゾチアゾリウム塩、ニトロインダゾール類、クロロベン
ズイミダゾール類、ブロモベンズイミダゾール類、メル
カプトチアゾール類、メルカプトベンゾチアゾール類、
メルカプトチアジアゾール類、アミノトリアゾール類、
ベンゾチアゾール類、ニトロベンゾトリアゾール類、な
ど;メルカプトピリミジン類;メルカプトトリアジン
類;たとえばオキサゾリンチオンのようなチオケト化合
物;アザインデン類、たとえばトリアザインデン類、テ
トラアザインデン類(特に4−ヒドロキシ置換(1,
3,3a,7)テトラザインデン類)、ペンタアザイン
デン類など;ベンゼンチオスルフォン酸、ベンゼンスル
フィン酸、ベンゼンスルフォン酸アミド等のようなカブ
リ防止剤または安定剤として知られた多くの化合物を加
えることができる。The light-sensitive material of the present invention can contain various compounds for the purpose of preventing fog during the production process, storage or photographic processing of the light-sensitive material or stabilizing photographic performance. That is, azoles such as benzothiazolium salts, nitroindazoles, chlorobenzimidazoles, bromobenzimidazoles, mercaptothiazoles, mercaptobenzothiazoles,
Mercaptothiadiazoles, aminotriazoles,
Benzothiazoles, nitrobenzotriazoles, etc .; mercaptopyrimidines; mercaptotriazines; thioketo compounds such as oxazolinethione; azaindenes such as triazaindenes, tetraazaindenes (especially 4-hydroxy-substituted (1,
3,3a, 7) tetrazaindenes), pentaazaindenes and the like; many compounds known as antifoggants or stabilizers such as benzenethiosulfonic acid, benzenesulfinic acid, benzenesulfonamide and the like are added. be able to.
【0060】特にポリヒドロキシベンゼン化合物は、感
度を損うことなく耐圧力性を向上させる点で好ましい。
ポリヒドロキシベンゼン化合物は下記のいづれかの構造
を持つ化合物であることが好ましい。In particular, polyhydroxybenzene compounds are preferred in that they improve pressure resistance without impairing sensitivity.
The polyhydroxybenzene compound is preferably a compound having any one of the following structures.
【0061】[0061]
【化26】 Embedded image
【0062】XとYはそれぞれ−H、−OH、ハロゲン
原子−OM(Mはアルカリ金属イオン)、−アルキル
基、フェニル基、アミノ基、カルボニル基、スルホン
基、スルホン化フェニル基、スルホン化アルキル基、ス
ルホン化アミノ基、スルホン化カルボニル基、カルボキ
シフェニル基、カルボキシアルキル基、カルボキシアミ
ノ基、ヒドロキシフェニル基、ヒドロキシアルキル基、
アルキルエーテル基、アルキルフェニル基、アルキルチ
オエーテル基、又はフェニルチオエーテル基である。さ
らに好ましくは、−H、−OH、−Cl、−Br、−C
OOH、−CH2 CH2 COOH、−CH3 、−CH2
CH3 、−CH(CH3 )2 、−C(CH3 )3 、−O
CH3 、−CHO、−SO3 Na、−SO3 H、−SC
H3 、X and Y are each -H, -OH, halogen atom -OM (M is an alkali metal ion), -alkyl group, phenyl group, amino group, carbonyl group, sulfone group, sulfonated phenyl group, sulfonated alkyl group. Group, sulfonated amino group, sulfonated carbonyl group, carboxyphenyl group, carboxyalkyl group, carboxyamino group, hydroxyphenyl group, hydroxyalkyl group,
An alkyl ether group, an alkylphenyl group, an alkylthioether group, or a phenylthioether group. More preferably, -H, -OH, -Cl, -Br, -C
OOH, -CH 2 CH 2 COOH, -CH 3, -CH 2
CH 3, -CH (CH 3) 2, -C (CH 3) 3, -O
CH 3, -CHO, -SO 3 Na , -SO 3 H, -SC
H 3 ,
【0063】[0063]
【化27】 Embedded image
【0064】などである。XとYは同じでも異なってい
てもよい。特に好ましい代表的化合物例を以下に示す。And so on. X and Y may be the same or different. Particularly preferred representative compounds are shown below.
【0065】[0065]
【化28】 Embedded image
【0066】[0066]
【化29】 Embedded image
【0067】[0067]
【化30】 Embedded image
【0068】[0068]
【化31】 Embedded image
【0069】ポリヒドロキシベンゼン化合物は、感材中
の乳剤層に添加しても、乳剤層以外の層中に添加しても
良い。添加量は1モルに対して10-5〜1モルの範囲が
有効であり、10-3モル〜10-1モルの範囲が特に有効
である。The polyhydroxybenzene compound may be added to the emulsion layer in the light-sensitive material or may be added to a layer other than the emulsion layer. The amount added is preferably in the range of 10 -5 to 1 mol per mol, and particularly preferably in the range of 10 -3 to 10 -1 mol.
【0070】本発明を用いて作られた感光材料には、親
水性コロイド層にフィルター染料として、あるいはイラ
ジエーション防止その他種々の目的で水溶性染料を含有
していてもよい。このような染料には、オキソノール染
料、ヘミオキソノール染料、スチリル染料、メロシアニ
ン染料、シアニン染料及びアゾ染料が包含される。なか
でもオキソノール染料;ヘミオキソノール染料及びメロ
シアニン染料が有用である。The light-sensitive material prepared by using the present invention may contain a water-soluble dye as a filter dye in the hydrophilic colloid layer or for various purposes such as prevention of irradiation. Such dyes include oxonol dyes, hemioxonol dyes, styryl dyes, merocyanine dyes, cyanine dyes and azo dyes. Among them, oxonol dyes; hemioxonol dyes and merocyanine dyes are useful.
【0071】本発明の写真感光材料の写真乳剤層には感
度上昇、コントラスト上昇、または現像促進の目的で、
たとえばポリアルキレンオキシドまたはそのエーテル、
エステル、アミンなどの誘導体、チオエーテル化合物、
チオモルフォリン類、四級アンモニウム塩化合物、ウレ
タン誘導体、尿素誘導体、イミダゾール誘導体、3−ピ
ラゾリドン類アミノフェノール類等の現像主薬を含んで
も良い。なかでも3−ピラゾリドン類(1−フェニル−
3−ピラゾリドン、1−フェニル−4−メチル−4−ヒ
ドロキシメチル−3−ピラゾリドンなど)が好ましく、
通常5g/m2以下で用いられ、0.01〜0.2g/m2
がより好ましい。In the photographic emulsion layer of the photographic light-sensitive material of the present invention, for the purpose of increasing sensitivity, increasing contrast, or promoting development,
For example, polyalkylene oxide or its ether,
Derivatives such as esters and amines, thioether compounds,
Developing agents such as thiomorpholines, quaternary ammonium salt compounds, urethane derivatives, urea derivatives, imidazole derivatives, 3-pyrazolidones and aminophenols may be contained. Among them, 3-pyrazolidones (1-phenyl-
3-pyrazolidone, 1-phenyl-4-methyl-4-hydroxymethyl-3-pyrazolidone) are preferred,
Usually used at 5 g / m 2 or less, 0.01 to 0.2 g / m 2
Is more preferred.
【0072】本発明の写真乳剤及び非感光性の親水性コ
ロイドには無機または有機の硬膜剤を含有してよい。例
えば活性ビニル化合物(1,3,5−トリアクリロイル
−ヘキサヒドロ−s−トリアジン、ビス(ビニルスルホ
ニル)メチルエーテル、N,N−メチレンビス−〔β−
(ビニルスルホニル)プロピオンアミド〕など)、活性
ハロゲン化合物(2,4−ジクロル−6−ヒドロキシ−
s−トリアジンなど)ムコハロゲン酸類(ムコクロル酸
など)、N−カルバモイルピリジニウム塩類((1−モ
ルホリ)カルボニル−3−ピリジニオ)メタンスルホナ
ートなど)ハロアミジニウム塩類(1−(1−クロロ−
1−ピリジノメチレン)ピロリジニウム、2−ナフタレ
ンスルホナートなど)を単独または組合せて用いること
ができる。なかでも、特開昭53−41220、同53
−57257、同59−162546、同60−808
46に記載の活性ビニル化合物および米国特許3,32
5,287号に記載の活性ハロゲン化物が好ましい。The photographic emulsion and the non-photosensitive hydrophilic colloid of the present invention may contain an inorganic or organic hardener. For example, active vinyl compounds (1,3,5-triacryloyl-hexahydro-s-triazine, bis (vinylsulfonyl) methyl ether, N, N-methylenebis- [β-
(Vinylsulfonyl) propionamide]), an active halogen compound (2,4-dichloro-6-hydroxy-
s-triazine, etc.) mucohalogenic acids (such as mucochloric acid), N-carbamoylpyridinium salts (such as (1-morpholy) carbonyl-3-pyridinio) methanesulfonate) haloamidinium salts (1- (1-chloro-
1-pyridinomethylene) pyrrolidinium, 2-naphthalene sulfonate, etc.) can be used alone or in combination. In particular, JP-A-53-41220 and JP-A-53-41220
-57257, 59-162546, 60-808
Active vinyl compound described in No. 46 and US Pat.
The active halides described in 5,287 are preferred.
【0073】本発明を用いて作られる感光材料の写真乳
剤層または他の親水性コロイド層には塗布助剤、帯電防
止、スベリ性改良、乳化分散、接着防止及び写真特性改
良(例えば、現像促進、硬調化、増感)等種々の目的
で、種々の界面活性剤を含んでもよい。例えばサポニン
(ステロイド系)、アルキレンオキサイド誘導体(例え
ばポリエチレングリコール、ポリエチレングリコール/
ポリプロピレングリコール縮合物、ポリエチレングリコ
ールアルキルエーテル類又はポリエチレングリコールア
ルキルアリールエーテル類、ポリエチレングリコールエ
ステル類、ポリエチレングリコールソルビタンエステル
類、ポリアルキレングリコールアルキルアミン又はアミ
ド類、シリコーンのポリエチレンオキサイド付加物
類)、グリシドール誘導体(例えばアルケニルコハク酸
ポリグリセリド、アルキルフェノールポリグリセリ
ド)、多価アルコールの脂肪酸エステル類、糖のアルキ
ルエステル類などの非イオン性界面活性剤;アルキルカ
ルボン酸塩、アルキルスルフォン酸塩、アルキルベンゼ
ンスルフォン酸塩、アルキルナフタレンスルフォン酸
塩、アルキル硫酸エステル類、アルキルリン酸エステル
類、N−アシル−N−アルキルタウリン類、スルホコハ
ク酸エステル類、スルホアルキルポリオキシエチレンア
ルキルフェニルエーテル類、ポリオキシエチレンアルキ
ルリン酸エステル類などのような、カルボキシ基、スル
ホ基、ホスホ基、硫酸エステル基、リン酸エステル基等
の酸性基を含むアニオン界面活性剤;アミノ酸類、アミ
ノアルキルスルホン酸類、アミノアルキル硫酸又はリン
酸エステル類、アルキルベタイン類、アミンオキシド類
などの両性界面活性剤;アルキルアミン塩類、脂肪族あ
るいは芳香族第4級アンモニウム塩類、ピリジニウム、
イミダゾリウムなどの複素環第4級アンモニウム塩類、
及び脂肪族又は複素環を含むホスホニウム又はスルホニ
ウム塩類などのカチオン界面活性剤を用いることができ
る。また、帯電防止のためには特開昭60−80849
号などに記載された含フッ素系界面活性剤を用いること
が好ましい。The photographic emulsion layer or other hydrophilic colloid layer of the light-sensitive material prepared by using the present invention may have a coating aid, antistatic property, improvement of slipperiness, emulsification / dispersion, prevention of adhesion and improvement of photographic properties (for example, development acceleration). For various purposes such as contrast enhancement, sensitization, and the like, various surfactants may be contained. For example, saponins (steroids), alkylene oxide derivatives (eg, polyethylene glycol, polyethylene glycol /
Polypropylene glycol condensates, polyethylene glycol alkyl ethers or polyethylene glycol alkyl aryl ethers, polyethylene glycol esters, polyethylene glycol sorbitan esters, polyalkylene glycol alkylamines or amides, polyethylene oxide adducts of silicone), glycidol derivatives ( For example, nonionic surfactants such as alkenyl succinic acid polyglyceride and alkylphenol polyglyceride), fatty acid esters of polyhydric alcohols and alkyl esters of sugars; alkyl carboxylate, alkyl sulfonate, alkyl benzene sulfonate, alkyl Naphthalene sulfonates, alkyl sulfates, alkyl phosphates, N-acyl-N-alkyl Such as taurine, sulfosuccinates, sulfoalkyl polyoxyethylene alkyl phenyl ethers, polyoxyethylene alkyl phosphates, carboxy group, sulfo group, phospho group, sulfate group, phosphate group, etc. Anionic surfactants containing an acidic group; amphoteric surfactants such as amino acids, aminoalkyl sulfonic acids, aminoalkyl sulfates or phosphates, alkyl betaines, amine oxides; alkylamine salts, aliphatic or aromatic Quaternary ammonium salts, pyridinium,
Heterocyclic quaternary ammonium salts such as imidazolium,
And cationic surfactants such as phosphonium or sulfonium salts containing aliphatic or heterocyclic rings. In order to prevent charging, Japanese Patent Application Laid-Open No. Sho 60-80849
It is preferable to use the fluorinated surfactant described in the above item.
【0074】本発明の写真感光材料には写真乳剤層その
他の親水性コロイド層に接着防止の目的でシリカ、酸化
マグネシウム、ポリメチルメタクリレート等のマット剤
を含むことができる。本発明で用いられる感光材料には
寸度安定性の目的で水不溶または難溶性合成ポリマーの
分散物を含むことができる。たとえばアルキル(メタ)
アクリレート、アルコキシアクリル(メタ)アクリレー
ト、グリシジル(メタ)アクリレート、などの単独もし
くは組合わせ、またはこれらとアクリル酸、メタアクリ
ル酸、などの組合せを単量体成分とするポリマーを用い
ることができる。写真乳剤の縮合剤または保護コロイド
としては、ゼラチンを用いるのが有利であるが、それ以
外の親水性コロイドも用いることができる。たとえばゼ
ラチン誘導体、ゼラチンと他の高分子とのグラフトポリ
マー、アルブミン、カゼイン等の蛋白質;ヒドロキシエ
チルセルロース、カルボキシメチルセルロース、セルロ
ース硫酸エステル類等の如きセルロース誘導体、アルギ
ン酸ソーダ、澱粉誘導体などの糖誘導体、ポリビニルア
ルコール、ポリビニルアルコール部分アセタール、ポリ
−N−ビニルピロリドン、ポリアクリル酸、ポリメタク
リル酸、ポリアクリルアミド、ポリビニルイミダゾー
ル、ポリビニルピラゾール等の単一あるいは共重合体の
如き多種の合成親水性高分子物質を用いることができ
る。ゼラチンとしては石灰処理ゼラチンのほか、酸処理
ゼラチンを用いてもよく、ゼラチン加水分解物、ゼラチ
ン酵素分解物も用いることができる。本発明で用いられ
るハロゲン化銀乳剤層には、アルキルアクリレートの如
きポリマーラテックスを含有せしめることができる。本
発明の感光材料の支持体としてはセルロース、トリアセ
テート、セルロースジアセテート、ニトロセルロース、
ポリスチレン、ポリエチレンテレフタレート紙、バライ
タ塗覆紙、ポリオレフィン被覆紙などを用いることがで
きる。The photographic light-sensitive material of the present invention may contain a matting agent such as silica, magnesium oxide or polymethyl methacrylate for the purpose of preventing adhesion to a photographic emulsion layer or other hydrophilic colloid layers. The light-sensitive material used in the present invention may contain a dispersion of a water-insoluble or hardly soluble synthetic polymer for the purpose of dimensional stability. For example, alkyl (meth)
A polymer having a monomer component of acrylate, alkoxyacryl (meth) acrylate, glycidyl (meth) acrylate, or the like alone or in combination, or a combination thereof with acrylic acid, methacrylic acid, or the like can be used. Gelatin is advantageously used as a condensing agent or protective colloid of the photographic emulsion, but other hydrophilic colloids can also be used. For example, gelatin derivatives, graft polymers of gelatin and other macromolecules, proteins such as albumin and casein; cellulose derivatives such as hydroxyethylcellulose, carboxymethylcellulose and cellulose sulfates; sugar derivatives such as sodium alginate and starch derivatives; polyvinyl alcohol Use of various kinds of synthetic hydrophilic high-molecular substances such as mono- or copolymers such as polyvinyl alcohol partial acetal, poly-N-vinylpyrrolidone, polyacrylic acid, polymethacrylic acid, polyacrylamide, polyvinylimidazole and polyvinylpyrazole Can be. As gelatin, in addition to lime-processed gelatin, acid-processed gelatin may be used, and gelatin hydrolyzate and gelatin enzyme hydrolyzate can also be used. The silver halide emulsion layer used in the present invention may contain a polymer latex such as an alkyl acrylate. As the support of the light-sensitive material of the present invention, cellulose, triacetate, cellulose diacetate, nitrocellulose,
Polystyrene, polyethylene terephthalate paper, baryta-coated paper, polyolefin-coated paper, and the like can be used.
【0075】本発明に使用する現像液に用いる現像主薬
には特別な制限はないが、良好な網点品質を得やすい点
で、ジヒドロキシベンゼン類を含むことが好ましく、ジ
ヒドロキシベンゼン類と1−フェニル−3−ピラゾリド
ン類の組合せまたはジヒドロキシベンゼン類とp−アミ
ノフェノール類の組合せを用いる場合もある。本発明に
用いるジヒドロキシベンゼン現像主薬としてはハイドロ
キノン、クロロハイドロキノン、ブロムハイドロキノ
ン、イソプロピルハイドロキノン、メチルハイドロキノ
ン、2,3−ジクロロハイドロキノン、2,5−ジクロ
ロハイドロキノン、2,3−ジブロムハイドロキノン、
2,5−ジメチルハイドロキノンなどがあるが特にハイ
ドロキノンが好ましい。本発明に用いる1−フェニル−
3−ピラゾリドン又はその誘導体の現像主薬としては1
−フェニル−3−ピラゾリドン、1−フェニル−4,4
−ジメチル−3−ピラゾリドン、1−フェニル−4−メ
チル−4−ヒドロキシメチル−3−ピラゾリドン、1−
フェニル−4,4−ジヒドロキシメチル−3−ピラゾリ
ドン、1−フェニル−5−メチル−3−ピラゾリドン、
1−p−アミノフェニル−4,4−ジメチル−3−ピラ
ゾリドン、1−p−トリル−4,4−ジメチル−3−ピ
ラゾリドン、1−p−トリル−4−メチル−4−ヒドロ
キシメチル−3−ピラゾリドンなどがある。本発明に用
いるp−アミノフェノール系現像主薬としてはN−メチ
ル−p−アミノフェノール、p−アミノフェノール、N
−(β−ヒドロキシエチル)−p−アミノフェノール、
N−(4−ヒドロキシフェニル)グリシン、2−メチル
−p−アミノフェノール、p−ベンジルアミノフェノー
ル等があるが、なかでもN−メチル−p−アミノフェノ
ールが好ましい。現像主薬は通常0.05モル/リット
ル〜0.8モル/リットルの量で用いられるのが好まし
い。またジヒドロキシベンゼン類と1−フェニル−3−
ピラゾリドン類又はp・アミノ・フェノール類との組合
せを用いる場合には前者を0.05モル/リットル−
0.5モル/リットル、後者を0.06モル/リットル
以下の量で用いるのが好ましい。本発明に用いる亜硫酸
塩の保恒剤としては亜硫酸ナトリウム、亜硫酸カリウ
ム、亜硫酸リチウム、亜硫酸アンモニウム、重亜硫酸ナ
トリウム、メタ重亜硫酸カリウム、ホルムアルデヒド重
亜硫酸ナトリウムなどがある。亜硫酸塩は0.3モル/
リントル以上、特に0.4モル/リットル以上が好まし
い。また上限は2.5モル/リットルまで、特に、1.
2までとするのが好ましい。The developing agent used in the developer used in the present invention is not particularly limited, but preferably contains dihydroxybenzenes from the viewpoint that good halftone dot quality can be easily obtained. A combination of -3-pyrazolidones or a combination of dihydroxybenzenes and p-aminophenols may be used. As the dihydroxybenzene developing agent used in the present invention, hydroquinone, chlorohydroquinone, bromohydroquinone, isopropylhydroquinone, methylhydroquinone, 2,3-dichlorohydroquinone, 2,5-dichlorohydroquinone, 2,3-dibromohydroquinone,
There are 2,5-dimethylhydroquinone and the like, but hydroquinone is particularly preferred. 1-phenyl- used in the present invention
The developing agent for 3-pyrazolidone or a derivative thereof is 1
-Phenyl-3-pyrazolidone, 1-phenyl-4,4
-Dimethyl-3-pyrazolidone, 1-phenyl-4-methyl-4-hydroxymethyl-3-pyrazolidone, 1-
Phenyl-4,4-dihydroxymethyl-3-pyrazolidone, 1-phenyl-5-methyl-3-pyrazolidone,
1-p-aminophenyl-4,4-dimethyl-3-pyrazolidone, 1-p-tolyl-4,4-dimethyl-3-pyrazolidone, 1-p-tolyl-4-methyl-4-hydroxymethyl-3- And pyrazolidone. Examples of the p-aminophenol-based developing agent used in the present invention include N-methyl-p-aminophenol, p-aminophenol and N-methylphenol.
-(Β-hydroxyethyl) -p-aminophenol,
There are N- (4-hydroxyphenyl) glycine, 2-methyl-p-aminophenol, p-benzylaminophenol and the like, among which N-methyl-p-aminophenol is preferable. The developing agent is preferably used in an amount of usually 0.05 mol / l to 0.8 mol / l. Also, dihydroxybenzenes and 1-phenyl-3-
When a combination with pyrazolidones or p-amino-phenols is used, the former is used in an amount of 0.05 mol / liter.
It is preferred to use 0.5 mol / l and the latter in an amount of 0.06 mol / l or less. Examples of the sulfite preservative used in the present invention include sodium sulfite, potassium sulfite, lithium sulfite, ammonium sulfite, sodium bisulfite, potassium metabisulfite, and formaldehyde sodium bisulfite. 0.3 mol of sulfite /
It is preferably at least lintole, especially at least 0.4 mol / l. The upper limit is up to 2.5 mol / l, especially 1.
It is preferably up to 2.
【0076】pHの設定のために用いるアルカリ剤には水
酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、炭
酸カリウム、第三リン酸ナトリウム、第三リン酸カリウ
ム、ケイ酸ナトリウム、ケイ酸カリウムの如きpH調節剤
や緩衝剤を含む。上記成分以外に用いられる添加剤とし
てはホウ酸、ホウ砂などの化合物、臭化ナトリウム、臭
化カリウム、沃化カリウムの如き現像抑制剤:エチレン
グリコール、ジエチレングリコール、トリエチレングリ
コール、ジメチルホルムアミド、メチルセロソルブ、ヘ
キシレングリコール、エタノール、メタノールの如き有
機溶剤:1−フェニル−5−メルカプトテトラゾール、
2−メルカプトベンツイミダゾール−5−スルホン酸ナ
トリウム塩等のメルカプト系化合物、5−ニトロインダ
ゾール等のインダゾール系化合物、5−メチルベンツト
リアゾール等のベンツトリアゾール系化合物などのカブ
リ防止剤を含んでもよく、更に必要に応じて色調剤、界
面活性剤、消泡剤、硬水軟化剤、硬膜剤、などを含んで
もよい。特に特開昭56−106244号に記載のアミ
ノ化合物、特公昭48−35493号に記載のイミダゾ
ール化合物が現像促進あるいは感度上昇という点で好ま
しい。本発明に用いられる現像液には、銀汚れ防止剤と
して特開昭56−24347号に記載の化合物、現像ム
ラ防止剤として(特開昭62−212,651号)に記
載の化合物、溶解助剤として特開昭61−267759
号に記載の化合物を用いることができる。The alkaline agent used for setting the pH includes pH such as sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium tertiary phosphate, potassium tertiary phosphate, sodium silicate and potassium silicate. Contains regulators and buffers. Additives other than the above components include compounds such as boric acid and borax, and development inhibitors such as sodium bromide, potassium bromide and potassium iodide: ethylene glycol, diethylene glycol, triethylene glycol, dimethylformamide, methyl cellosolve , Organic solvents such as hexylene glycol, ethanol and methanol: 1-phenyl-5-mercaptotetrazole,
It may contain an antifoggant such as a mercapto compound such as 2-mercaptobenzimidazole-5-sulfonic acid sodium salt, an indazole compound such as 5-nitroindazole, and a benztriazole compound such as 5-methylbenztriazole. If necessary, a color tone agent, a surfactant, an antifoaming agent, a water softener, a hardener, and the like may be contained. In particular, amino compounds described in JP-A-56-106244 and imidazole compounds described in JP-B-48-35493 are preferred in terms of accelerating development or increasing sensitivity. The developer used in the present invention contains a compound described in JP-A-56-24347 as a silver stain inhibitor, a compound described in JP-A-62-212,651 as a development unevenness inhibitor, and a dissolution aid. JP-A-61-267759 as an agent
Can be used.
【0077】定着液は定着剤の他に必要に応じて硬膜剤
(例えば水溶性アルミニウム化合物)、酢酸及び二塩基
酸(例えば酒石酸、クエン酸又はこれらの塩)を含む水
溶液であり、好ましくは、pH3.8以上、より好ましく
は4.0〜5.5を有する。定着剤としてはチオ硫酸ナ
トリウム、チオ硫酸アンモニウムなどであり、定着速度
の点からチオ硫酸アンモニウムが特に好ましい。定着剤
の使用量は適宜変えることができ、一般には約0.1〜
約5モル/リットルである。定着液中で主として硬膜剤
として使用する水溶性アルミニウム塩は一般に酸性硬膜
定着液の硬膜剤として知られている化合物であり、例え
ば塩化アルミニウム、硫酸アルミニウム、カリ明ばんな
どがある。前述の二塩基酸として、酒石酸あるいはその
誘導体、クエン酸あるいはその誘導体が単独で、あるい
は二種以上を併用することができる。これらの化合物は
定着液1リットルにつき、0.005モル以上含むもの
が有効で、特に0.01モル/リットル〜0.03モル
/リットルが特に有効である。具体的には、酒石酸、酒
石酸カリウム、酒石酸ナトリウム、酒石酸カリウムナト
リウム、酒石酸アンモニウム、酒石酸アンモニウムカリ
ウム、などがある。本発明において有効なクエン酸ある
いはその誘導体の例としてクエン酸、クエン酸ナトリウ
ム、クエン酸カリウム、などがある。定着液にはさらに
所望により保恒剤(例えば、亜硫酸塩、重亜硫酸塩)、
pH緩衝剤(例えば、酢酸、硼酸)、pH調整剤(例えば、
アンモニア、硫酸)、画像保存良化剤(例えば沃化カ
リ)、キレート剤を含むことができる。ここでpH緩衝剤
は、現像液のpHが高いので10〜40g/リットル、よ
り好ましくは18〜25g/リットル程度用いる。The fixing solution is an aqueous solution containing a hardening agent (for example, a water-soluble aluminum compound), acetic acid and a dibasic acid (for example, tartaric acid, citric acid or a salt thereof), if necessary, in addition to the fixing agent. , PH 3.8 or more, more preferably 4.0 to 5.5. Examples of the fixing agent include sodium thiosulfate and ammonium thiosulfate, and ammonium thiosulfate is particularly preferable from the viewpoint of fixing speed. The amount of the fixing agent can be appropriately changed, and is generally about 0.1 to
About 5 mol / l. The water-soluble aluminum salt mainly used as a hardening agent in the fixing solution is a compound generally known as a hardening agent for an acidic hardening fixing solution, and examples thereof include aluminum chloride, aluminum sulfate and potassium alum. As the above-mentioned dibasic acid, tartaric acid or a derivative thereof, citric acid or a derivative thereof can be used alone or in combination of two or more. It is effective that these compounds contain 0.005 mol or more per liter of the fixing solution, and particularly 0.01 to 0.03 mol / l is particularly effective. Specifically, there are tartaric acid, potassium tartrate, sodium tartrate, potassium sodium tartrate, ammonium tartrate, potassium ammonium tartrate, and the like. Examples of citric acid or a derivative thereof effective in the present invention include citric acid, sodium citrate, potassium citrate, and the like. The fixing solution may further contain a preservative (for example, sulfite or bisulfite), if desired.
pH buffers (eg, acetic acid, boric acid), pH adjusters (eg,
Ammonia, sulfuric acid), an image preserving agent (eg, potassium iodide), and a chelating agent. Here, the pH buffer is used in an amount of 10 to 40 g / liter, more preferably about 18 to 25 g / liter, because the pH of the developer is high.
【0078】本発明の感光材料は全処理時間が15秒〜
60秒である自動現像機による迅速現像処理にすぐれた
性能を示す。本発明の迅速現像処理において、現像、定
着の温度および時間は約25℃〜50℃で各々25秒以
下であるが、好ましくは30℃〜40℃で4秒〜15秒
である。本発明においては感光材料は現像、定着された
後水洗または安定化処理に施される。ここで、水洗工程
は、2〜3段の向流水洗方式を用いることによって節水
処理することができる。また少量の水洗水で水洗すると
きにはスクイズローラー洗浄槽を設けることが好まし
い。更に、水洗浴または定着浴からのオーバーフロー液
の一部または全部は特開昭60−235133号に記載
されているように定着液に利用することも出来る。こう
することによって廃液量も減少しより好ましい。また、
水洗水には、カビ防止剤(例えば堀口著「防菌防ばいの
化学」、特開昭62−115154号公報に記載の化合
物)、水洗促進剤(亜硫酸塩など)、キレート剤などを
含有していてもよい。上記の方法による水洗または安定
浴の温度及び時間は0℃〜50℃で5秒〜30秒である
が、15℃〜40℃で4秒〜20秒が好ましい。本発明
では現像、定着、水洗された感光材料はスクイズローラ
ーを経て乾燥される。乾燥は40℃〜80℃で4秒〜3
0秒で行われる。本発明における全処理時間とは自動現
像機の挿入口にフィルムの先端を挿入してから、現像
槽、渡り部分、定着槽、渡り部分、水洗槽、渡り部分、
乾燥部分を通過して、フィルムの先端が乾燥出口からで
でくるまでの全時間である。以下本発明を実施例によっ
て具体的に説明するが、本発明がこれらによって限定さ
れるものではない。The photosensitive material of the present invention has a total processing time of 15 seconds to
It shows excellent performance in rapid development processing by an automatic developing machine for 60 seconds. In the rapid development processing of the present invention, the temperature and time for development and fixing are each about 25 ° C. to 50 ° C. for 25 seconds or less, preferably 30 ° C. to 40 ° C. for 4 seconds to 15 seconds. In the present invention, after the photosensitive material is developed and fixed, it is subjected to washing or stabilizing treatment. Here, in the rinsing step, water can be saved by using a two- or three-stage countercurrent rinsing method. When washing with a small amount of washing water, a squeeze roller washing tank is preferably provided. Further, a part or all of the overflow solution from the washing bath or the fixing bath can be used for the fixing solution as described in JP-A-60-235133. By doing so, the amount of waste liquid is reduced, which is more preferable. Also,
The washing water contains a fungicide (for example, a compound described in Horiguchi, "The Chemistry of Bacterial Prevention and Prevention", JP-A-62-115154), a washing accelerator (sulfite, etc.), a chelating agent and the like. May be. The temperature and time of the water washing or stabilizing bath according to the above method are 0 ° C to 50 ° C for 5 seconds to 30 seconds, preferably 15 ° C to 40 ° C for 4 seconds to 20 seconds. In the present invention, the photosensitive material that has been developed, fixed and washed with water is dried through a squeeze roller. Drying at 40 ° C to 80 ° C for 4 seconds to 3
This is done in 0 seconds. The total processing time in the present invention means that after inserting the leading end of the film into the insertion opening of the automatic developing machine, a developing tank, a transfer section, a fixing tank, a transfer section, a washing tank, a transfer section,
This is the total time from the drying section to the end of the film coming out of the drying outlet. Hereinafter, the present invention will be described specifically with reference to Examples, but the present invention is not limited thereto.
【0079】[0079]
実施例1 以下の方法により、乳剤〔A〕〜〔E〕を調整した。 〔乳剤A〕0.13Mの硝酸銀水溶液と、0.04Mの
臭化カリウムと0.1Mの塩化ナトリウムを含むハロゲ
ン塩水溶液を、塩化ナトリウムと1,3−ジメチルイミ
ダゾリジン−2−チオンを含有するゼラチン水溶液に、
攪拌しながら43℃で12分間ダブルジェット法により
添加し、平均粒子サイズ0.15μm、塩化銀含有率7
0モル%の塩臭化銀粒子を得ることにより核形成を行な
った。続いて同様に0.87Mの硝酸銀水溶液と0.2
6Mの臭化カリウムと0.65Mの塩化ナトリウムを含
むハロゲン塩水溶液をダブルジェット法により20分間
かけて添加した。その後常法に従ってフロキュレーショ
ン法により水洗し、ゼラチン40gを加え、pH6.5、
pAg7.5に調整し、さらに銀1モルあたりベンゼン
チオスルホン酸ナトリウム20mg、チオ硫酸ナトリウム
5mgおよび塩化金酸8mgを加え、60℃で75分間加熱
し、化学増感処理を施し、安定剤として4−ヒドロキシ
−6−メチル−1,3,3a,7−テトラアザインデン
150mgを加えた。得られた粒子は、平均粒子サイズ
0.26μm、塩化銀含量70モル%の塩臭化銀立方体
粒子であった(変動係数10%)。 〔乳剤B〕核形成時に添加するハロゲン塩水溶液に、さ
らに(NH4 )3 RhCl6 とK3 IrCl6 を加えた
以外は乳剤Aと同様の方法により、平均粒子サイズ0.
26μm、塩化銀含量70モル%、銀1モルあたりRh
化合物を1×10-7モル、Ir化合物を5×10-7モル
含有する塩臭化銀立方体粒子を得た(変動係数10
%)。 〔乳剤C〕核形成時に添加するハロゲン塩水溶液に、さ
らにK3 IrCl6 とK2 Ru(NO)Cl5 を加えた
以外は乳剤Aと同様の方法により、平均粒子サイズ0.
26μm、塩化銀含量70モル%、銀1モルあたりIr
化合物を5×10-7モル、Ru化合物を1×10-7モル
含有する塩臭化銀立方体粒子を得た(変動係数10
%)。 〔乳剤D〕核形成時に添加するK3 IrCl6 の添加量
を調整し、粒子成長に用いるハロゲン塩水溶液にさらに
K4 〔Fe(CN)6 〕を加えた以外は、乳剤Bと同様
の方法により、平均粒子サイズ0.26μm、塩化銀含
量70モル%、銀1モルあたりRh化合物を1×10-7
モル、Ir化合物を2×10-7モル、Fe化合物を3×
10-5モル含有する塩臭化銀立方体粒子を得た(変動係
数10%)。 〔乳剤E〕核形成時に添加するK3 IrCl6 の添加量
を調整し、粒子成長に用いるハロゲン塩水溶液にさらに
K4 〔Fe(CN)6 〕を加えた以外は、乳剤Cと同様
の方法により、平均粒子サイズ0.26μm、塩化銀含
量70モル%、銀1モルあたりIr化合物を2×10-7
モル、Ru化合物を1×10-7モル、Fe化合物を3×
10-5モル含有する塩臭化銀立方体粒子を得た(変動係
数10%)。Example 1 Emulsions [A] to [E] were prepared by the following method. [Emulsion A] A 0.13 M aqueous solution of silver nitrate, an aqueous solution of a halogen salt containing 0.04 M of potassium bromide and 0.1 M of sodium chloride, containing sodium chloride and 1,3-dimethylimidazolidin-2-thione In an aqueous gelatin solution,
While stirring, the mixture was added by a double jet method at 43 ° C. for 12 minutes to give an average particle size of 0.15 μm and a silver chloride content of 7
Nucleation was performed by obtaining 0 mol% of silver chlorobromide grains. Subsequently, a 0.87 M silver nitrate aqueous solution and 0.2
A halogen salt aqueous solution containing 6 M potassium bromide and 0.65 M sodium chloride was added by a double jet method over 20 minutes. Thereafter, the mixture was washed with water by a flocculation method according to a conventional method, and 40 g of gelatin was added thereto.
The pAg was adjusted to 7.5, and 20 mg of sodium benzenethiosulfonate, 5 mg of sodium thiosulfate and 8 mg of chloroauric acid were added per mole of silver, and the mixture was heated at 60 ° C. for 75 minutes, subjected to a chemical sensitization treatment, and added as a stabilizer. 150 mg of -hydroxy-6-methyl-1,3,3a, 7-tetraazaindene were added. The obtained grains were cubic silver chlorobromide grains having an average grain size of 0.26 μm and a silver chloride content of 70 mol% (coefficient of variation: 10%). [Emulsion B] The same method as in Emulsion A except that (NH 4 ) 3 RhCl 6 and K 3 IrCl 6 were further added to the aqueous solution of the halogen salt added at the time of nucleation.
26 μm, silver chloride content 70 mol%, Rh per mol of silver
Silver chlorobromide cubic grains containing 1 × 10 −7 mol of the compound and 5 × 10 −7 mol of the Ir compound were obtained (coefficient of variation: 10 × 10 −7 mol).
%). [Emulsion C] The same method as in Emulsion A except that K 3 IrCl 6 and K 2 Ru (NO) Cl 5 were further added to the aqueous solution of the halogen salt added at the time of nucleation, and the average grain size was 0.1 mm.
26 μm, silver chloride content 70 mol%, Ir per mol of silver
Silver chlorobromide cubic particles containing 5 × 10 −7 mol of the compound and 1 × 10 −7 mol of the Ru compound were obtained (coefficient of variation: 10 × 10 −7 mol).
%). [Emulsion D] A method similar to Emulsion B except that the amount of K 3 IrCl 6 added during nucleation was adjusted, and K 4 [Fe (CN) 6 ] was further added to the aqueous halide solution used for grain growth. The average particle size was 0.26 μm, the silver chloride content was 70 mol%, and the Rh compound was 1 × 10 −7 per mol of silver.
Mole, 2 × 10 −7 mole of Ir compound, 3 × Fe compound
Silver chlorobromide cubic grains containing 10 -5 mol were obtained (coefficient of variation: 10%). [Emulsion E] A method similar to Emulsion C, except that the amount of K 3 IrCl 6 added during nucleation was adjusted and K 4 [Fe (CN) 6 ] was further added to the aqueous halide solution used for grain growth. The average particle size was 0.26 μm, the silver chloride content was 70 mol%, and the Ir compound was 2 × 10 −7 per mol of silver.
Mol, 1 × 10 -7 mol of Ru compound, 3 × Fe compound
Silver chlorobromide cubic grains containing 10 -5 mol were obtained (coefficient of variation: 10%).
【0080】塗布試料の作成 この様にして調整した乳剤A〜Eに下記増感色素を銀1
モルあたり30mg加えた。さらに強色増感および安定化
のために、4,4′−ビス(4,6−ジナフトキシ−ピ
リミジン−2−イルアミノ)−スチルベンジスルホン酸
ジナトリウム塩と2,5−ジメチル−3−アリル−ベン
ゾチアゾールヨード塩を銀1モルに対し、それぞれ30
0mgと450mg加えた。さらにハイドロキノン100mg
/m2、ポリエチルアクリレートラテックスをゼラチンバ
インダー比25%、硬膜剤として2−ビス(ビニルスル
ホニルアセトアミド)エタンを86mg/m2添加し、ポリ
エステル支持体上に、塗布銀量3.4g/m2、塗布ゼラ
チン量1.6g/m2になる様に塗布した。このとき保護
層として乳剤層の上側にゼラチンを0.5g/m2、下記
構造式の染料を20mg/m2、そしてマット剤として粒径
2.5μmのポリメチルメタクリレートを60mg/m2、
粒径10μmのコロイダルシリカを70mg/m2、また塗
布助剤としてドデシルベンゼンスルホン酸ナトリウム塩
と下記構造式の含フッ素界面活性剤を乳剤層と同時に塗
布した。Preparation of Coated Samples The following sensitizing dyes were added to the emulsions A to E prepared as described above in silver 1
30 mg was added per mole. Further, for supersensitization and stabilization, disodium salt of 4,4'-bis (4,6-dinaphthoxy-pyrimidin-2-ylamino) -stilbene disulfonic acid and 2,5-dimethyl-3-allyl-benzoate were used. Thiazole iodide salt was added in an amount of 30 moles per mole of silver.
0 mg and 450 mg were added. In addition, hydroquinone 100mg
/ M 2 , polyethyl acrylate latex at a gelatin binder ratio of 25%, 2-bis (vinylsulfonylacetamide) ethane as a hardener 86 mg / m 2 were added, and a coated silver amount of 3.4 g / m 2 was applied on a polyester support. 2. Coating was performed so that the coated gelatin amount was 1.6 g / m 2 . At this time, 0.5 g / m 2 of gelatin, 20 mg / m 2 of a dye represented by the following structural formula, 60 mg / m 2 of polymethyl methacrylate having a particle size of 2.5 μm as a matting agent were formed on the upper side of the emulsion layer as a protective layer.
70 mg / m 2 of colloidal silica having a particle diameter of 10 μm, and sodium dodecylbenzenesulfonate as a coating aid and a fluorine-containing surfactant having the following structural formula were coated simultaneously with the emulsion layer.
【0081】[0081]
【化32】 Embedded image
【0082】なお、本実施例で使用したベースは下記組
成のバック層およびバック保護層を有する。 〔バック層〕 ゼラチン 2.0g/m2 ドデシルベンゼンスルホン酸ナトリウム 80mg/m2 The base used in this example has a back layer and a back protective layer having the following compositions. [Back layer] Gelatin 2.0 g / m 2 Sodium dodecylbenzenesulfonate 80 mg / m 2
【0083】[0083]
【化33】 Embedded image
【0084】 1,3−ジビニルスルホン−2−プロパノール 60mg/m2 〔バック保護層〕 ゼラチン 0.5g/m2 ポリメチルメタクリレート(粒子サイズ4.7μm) 30mg/m2 ドデシルベンゼンスルホン酸ナトリウム 20mg/m2 含フッ素界面活性剤(前記) 2mg/m2 シリコーンオイル 100mg/m2 前記バック層に用いた染料1,3-divinylsulfone-2-propanol 60 mg / m 2 [Back protective layer] Gelatin 0.5 g / m 2 Polymethyl methacrylate (particle size 4.7 μm) 30 mg / m 2 Sodium dodecylbenzenesulfonate 20 mg / m 2 m 2 fluorine-containing surfactant (as described above) 2 mg / m 2 silicone oil 100 mg / m 2 Dye used in the back layer
【0085】写真性能の評価 得られた試料を、780nmにピークをもつ干渉フィルタ
ーと、連続ウェッジを介し、発光時間10-6sec のキセ
ノンフラッシュ光で露光し、富士写真フイルム(株)製
自動現像機FG−710NHを用いて、下記に示した温
度および時間でセンシトメトリーを行なった。Evaluation of photographic performance The obtained sample was exposed to xenon flash light having an emission time of 10 −6 sec through an interference filter having a peak at 780 nm and a continuous wedge, and was automatically developed by Fuji Photo Film Co., Ltd. Sensitometry was performed using the FG-710NH machine at the temperature and time indicated below.
【0086】 現 像 38℃ 14秒 9秒 定 着 37℃ 9.7秒 6.2秒 水 洗 26℃ 9秒 5.8秒 スクイズ 2.4秒 1.5秒 乾 燥 55℃ 8.3秒 5.3秒 合 計 43.4秒 27.8秒 用いた現像液及び定着液の組成は下記の如し。 〔現像液処方〕 ハイドロキノン 25.0g 4−メチル−4−ヒドロキシメチル−1−フェニル− 3−ピラゾリドン 0.5g 亜硫酸カリウム 90.0g エチレンジアミン四酢酸二ナトリウム 2.0g 臭化カリウム 5.0g 5−メチルベンゾトリアゾール 0.2g 2−メルカプトベンツイミダゾール−5−スルホン酸 0.3g 炭酸ナトリウム 20g 水を加えて 1リットル (水酸化ナトリウムを加えてpH=10.6に合わせる) 〔定着液処方〕 チオ硫酸アンモニウム 210g 亜硫酸ナトリウム(無水) 20g エチレンジアミン四酢酸2ナトリウム 0.1g 氷酢酸 15g 水を加えて 1リットル (アンモニア水でpH=4.8に合わせる)Current image 38 ° C. 14 seconds 9 seconds Fixing 37 ° C. 9.7 seconds 6.2 seconds Rinse 26 ° C. 9 seconds 5.8 seconds Squeeze 2.4 seconds 1.5 seconds Dry 55 ° C. 8.3 seconds 5.3 seconds total 43.4 seconds 27.8 seconds The composition of the developer and fixer used was as follows. [Developing solution formulation] Hydroquinone 25.0 g 4-methyl-4-hydroxymethyl-1-phenyl-3-pyrazolidone 0.5 g Potassium sulfite 90.0 g Disodium ethylenediaminetetraacetate 2.0 g Potassium bromide 5.0 g 5-methyl Benzotriazole 0.2g 2-Mercaptobenzimidazole-5-sulfonic acid 0.3g Sodium carbonate 20g Water 1 liter (add sodium hydroxide to adjust pH = 10.6) [Fixing solution formulation] Ammonium thiosulfate 210g Sodium sulfite (anhydrous) 20 g Disodium ethylenediaminetetraacetate 0.1 g Glacial acetic acid 15 g Add water 1 liter (Adjust to pH = 4.8 with aqueous ammonia)
【0087】濃度3.0を与える露光量の対数を感度と
し、相対感度で表1に示した。また特性曲線で濃度0.
1と3.0の点を結ぶ直線の傾きを階調とし、現像14
秒と9秒の感度差を現像進行として同じく表1に示し
た。表1からも明らかな様に、本発明の対応である試料
No. 3、5は高感、硬調であり、現像進行も速く迅速処
理適性に優れていることが理解される。The logarithm of the exposure amount giving a density of 3.0 was defined as the sensitivity, and the relative sensitivity is shown in Table 1. The characteristic curve shows a density of 0.
The gradient of the straight line connecting the points 1 and 3.0 is defined as the gradation, and
Table 1 also shows the difference in sensitivity between seconds and 9 seconds as development progress. As is clear from Table 1, the samples corresponding to the present invention
It is understood that Nos. 3 and 5 are high-sensitivity and high contrast, and the development progress is fast and the processability is excellent.
【0088】[0088]
【表1】 [Table 1]
【0089】[0089]
【発明の効果】本発明は、塩沃臭化銀乳剤において、乳
剤がニトロシル又はチオニトロシル配位子を有する周期
律表の第Va〜VIIa族またはVIII族の原子を含有し、さ
らに増感極大が750nmより長波長に分光増感するこ
とにより、赤外域に感色性を有する高照度露光用感光材
料を高感、高コントラストにすることができた。According to the present invention, there is provided a silver chloroiodobromide emulsion, wherein the emulsion contains an atom belonging to any one of groups Va to VIIa or VIII of the periodic table having a nitrosyl or thionitrosyl ligand. Was spectrally sensitized to a wavelength longer than 750 nm, whereby a photosensitive material for high illuminance exposure having a color sensitivity in the infrared region could have a high sensitivity and a high contrast.
Claims (2)
乳剤層を有するハロゲン化銀写真感光材料において、該
ハロゲン化銀乳剤が、ニトロシル又はチオニトロシル配
位子を有する周期律表の第Va〜第VIIa族又はVI
II族の元素から選択される遷移金属をハロゲン化銀1
モルあたり10−8〜1×10−6モル含有するハロゲ
ン化銀粒子からなり、かつ増感極大が750nmより長
波長に分光増感されていることを特徴とするハロゲン化
銀写真感光材料。1. A silver halide photographic material having at least one silver halide emulsion layer on a support, wherein the silver halide emulsion has a nitrosyl or thionitrosyl ligand. ~ Group VIIa or VI
A transition metal selected from Group II elements is silver halide 1
A silver halide photographic light-sensitive material comprising silver halide grains containing 10 -8 to 1 × 10 -6 mol per mol, and having a sensitization maximum spectrally sensitized to a wavelength longer than 750 nm.
像機で処理することを特徴とする請求項1のハロゲン化
銀写真感光材料の処理方法。2. The method for processing a silver halide photographic material according to claim 1, wherein the processing is carried out by an automatic developing machine having a total processing time of 15 to 60 seconds.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3103318A JP2847264B2 (en) | 1991-04-09 | 1991-04-09 | Silver halide photographic material and processing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3103318A JP2847264B2 (en) | 1991-04-09 | 1991-04-09 | Silver halide photographic material and processing method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04362931A JPH04362931A (en) | 1992-12-15 |
| JP2847264B2 true JP2847264B2 (en) | 1999-01-13 |
Family
ID=14350854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3103318A Expired - Fee Related JP2847264B2 (en) | 1991-04-09 | 1991-04-09 | Silver halide photographic material and processing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2847264B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69406562T2 (en) * | 1993-01-12 | 1998-06-04 | Eastman Kodak Co | Photographic silver halide emulsion containing contrast enhancing dopants |
| US5385817A (en) * | 1993-01-12 | 1995-01-31 | Eastman Kodak Company | Photographic emulsions containing internally and externally modified silver halide grains |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62145238A (en) * | 1985-12-20 | 1987-06-29 | Konishiroku Photo Ind Co Ltd | Silver halide photographic sensitive material |
| JPS63287849A (en) * | 1987-05-20 | 1988-11-24 | Fuji Photo Film Co Ltd | Image forming method |
| US4933272A (en) * | 1988-04-08 | 1990-06-12 | Eastman Kodak Company | Photographic emulsions containing internally modified silver halide grains |
-
1991
- 1991-04-09 JP JP3103318A patent/JP2847264B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04362931A (en) | 1992-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4677053A (en) | Silver halide photographic materials | |
| US5942384A (en) | Silver halide photographic materials and method for processing the same | |
| JP2884277B2 (en) | Silver halide photographic material | |
| JP2779734B2 (en) | Silver halide photographic material | |
| JP2847264B2 (en) | Silver halide photographic material and processing method thereof | |
| JPH01266536A (en) | Infra-red sensitive silver halide photosensitive material | |
| JP2640978B2 (en) | Silver halide photographic material | |
| JP2724639B2 (en) | Silver halide photographic material and processing method thereof | |
| JP2724635B2 (en) | Silver halide photographic material | |
| US5618660A (en) | Silver halide photographic material and method for processing the same | |
| JP2967879B2 (en) | Silver halide photographic material | |
| JP4184049B2 (en) | Silver halide photographic material | |
| JP2665608B2 (en) | Silver halide photographic light-sensitive material and processing method thereof | |
| JP3047269B2 (en) | Silver halide photographic material | |
| JP3023484B2 (en) | Silver halide photographic light-sensitive material and its development processing method | |
| USH1336H (en) | Silver halide photographic material | |
| JP2779731B2 (en) | Silver halide photographic material and processing method thereof | |
| JP2840891B2 (en) | Silver halide photographic material | |
| JPH04264544A (en) | Silver halide photographic sensitive material | |
| JPH05313289A (en) | Silver halide photographic sensitive material and method for processing same | |
| JP2724640B2 (en) | Silver halide photographic light-sensitive material and its development processing method | |
| JP2684242B2 (en) | Silver halide photographic material | |
| JP2767490B2 (en) | Silver halide emulsion | |
| JPH06194774A (en) | Silver halide photographic material and image forming method using it | |
| JPH0713289A (en) | Silver halide photographic sensitive material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |